"","X","miRNA","V2","V3.x","V4.x","V5","V6","V7","V8","V9","V10","V11","mRNA","PCC.cor","p_value","adjusted_p_value","V3.y","Protein.names","Organism","Gene.Ontology..biological.process.","Gene.Ontology.IDs"
"25",25,"Cluster_1015","Pocillopora_meandrina_HIv1___Sc0000002:9836558-9837558",159,-21.31,2,21,349,371,20,"70.00%","80.00%","Pocillopora_meandrina_HIv1___TS.g933.t1",-0.985707447203347,0.00204675233781541,0.667107103030161,"Q60803","TNF receptor-associated factor 3 (EC 2.3.2.27) (CD40 receptor-associated factor 1) (CRAF1) (CD40-binding protein) (CD40BP) (RING-type E3 ubiquitin transferase TRAF3)","Mus musculus (Mouse)","apoptotic process [GO:0006915]; innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of JNK cascade [GO:0046330]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of cytokine production [GO:0001817]; regulation of defense response to virus [GO:0050688]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of interferon-beta production [GO:0032648]; regulation of proteolysis [GO:0030162]; Toll signaling pathway [GO:0008063]; toll-like receptor signaling pathway [GO:0002224]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","GO:0001817; GO:0002224; GO:0005164; GO:0005739; GO:0005768; GO:0006915; GO:0008063; GO:0008270; GO:0009898; GO:0016740; GO:0019901; GO:0019903; GO:0030162; GO:0031625; GO:0031996; GO:0032088; GO:0032648; GO:0033209; GO:0035631; GO:0042802; GO:0042981; GO:0043122; GO:0045087; GO:0046330; GO:0050688; GO:0070534"
"44",44,"Cluster_1015","Pocillopora_meandrina_HIv1___Sc0000004:14085901-14086901",155,-20.37,2,17,577,599,16,"75.00%","87.50%","Pocillopora_meandrina_HIv1___RNAseq.g25124.t1",0.902074662164159,0.03624033280485,0.757701026778115,NA,NA,NA,NA,NA
"84",84,"Cluster_1015","Pocillopora_meandrina_HIv1___Sc0000008:12220857-12221857",161,-23.61,2,21,277,298,20,"80.00%","80.00%","Pocillopora_meandrina_HIv1___RNAseq.g2747.t1",-0.940728314065524,0.0171674364095079,0.674410729954476,NA,NA,NA,NA,NA
"121",121,"Cluster_1015","Pocillopora_meandrina_HIv1___Sc0000018:480449-481449",162,-26.15,2,21,504,527,21,"76.19%","80.95%","Pocillopora_meandrina_HIv1___RNAseq.g28187.t1",-0.924664032495435,0.0245396228914054,0.703130666452922,NA,NA,NA,NA,NA
"125",125,"Cluster_1015","Pocillopora_meandrina_HIv1___Sc0000019:5135697-5136037",158,-23.19,2,15,160,181,13,"84.62%","92.31%","Pocillopora_meandrina_HIv1___RNAseq.g18288.t1",-0.884601429844997,0.0462349592609459,0.782119655312028,NA,NA,NA,NA,NA
"146",146,"Cluster_1015","Pocillopora_meandrina_HIv1___Sc0000028:1530363-1531067",155,-21.4,2,12,225,246,10,"100.00%","100.00%","Pocillopora_meandrina_HIv1___RNAseq.g898.t1",0.952401399552824,0.0123765568551861,0.674410729954476,NA,NA,NA,NA,NA
"148",148,"Cluster_1015","Pocillopora_meandrina_HIv1___Sc0000028:417744-418744",164,-26.54,2,18,695,717,17,"82.35%","88.24%","Pocillopora_meandrina_HIv1___RNAseq.25719_t",-0.9403739893379,0.0173206670722916,0.674410729954476,NA,NA,NA,NA,NA
"151",151,"Cluster_1015","Pocillopora_meandrina_HIv1___Sc0000031:487162-488162",162,-24.46,2,21,396,416,19,"68.42%","89.47%","Pocillopora_meandrina_HIv1___RNAseq.g1339.t1",0.993733437088484,0.000594934716821626,0.667107103030161,"Q2TBK5","Transmembrane emp24 domain-containing protein 1 (p24 family protein gamma-1) (p24gamma1)","Bos taurus (Bovine)","endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]","GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0005886; GO:0006886; GO:0006888; GO:0007030; GO:0030134; GO:0033116"
"177",177,"Cluster_1068","Pocillopora_meandrina_HIv1___Sc0000000:4178754-4179754",151,-24.4,2,21,208,234,24,"66.67%","66.67%","Pocillopora_meandrina_HIv1___RNAseq.g21352.t1",-0.948311815246023,0.0139966677002161,0.674410729954476,NA,NA,NA,NA,NA
"194",194,"Cluster_1068","Pocillopora_meandrina_HIv1___Sc0000003:11037531-11038531",146,-30.01,2,21,828,856,26,"65.38%","65.38%","Pocillopora_meandrina_HIv1___RNAseq.g16022.t1",0.938779898628061,0.0180154908165704,0.674410729954476,NA,NA,NA,NA,NA
"195",195,"Cluster_1068","Pocillopora_meandrina_HIv1___Sc0000003:11037759-11038531",146,-30.01,2,21,600,628,26,"65.38%","65.38%","Pocillopora_meandrina_HIv1___TS.g11041.t1",0.959840752421338,0.00960237459287759,0.667107103030161,NA,NA,NA,NA,NA
"217",217,"Cluster_1068","Pocillopora_meandrina_HIv1___Sc0000006:10154697-10155697",157,-29.97,2,21,546,565,19,"73.68%","78.95%","Pocillopora_meandrina_HIv1___TS.g15059.t1",0.938779898628061,0.0180154908165704,0.674410729954476,NA,NA,NA,NA,NA
"223",223,"Cluster_1068","Pocillopora_meandrina_HIv1___Sc0000006:7636916-7637916",146,-30.01,2,21,828,856,26,"65.38%","65.38%","Pocillopora_meandrina_HIv1___RNAseq.g27489.t1",0.938779898628061,0.0180154908165704,0.674410729954476,NA,NA,NA,NA,NA
"232",232,"Cluster_1068","Pocillopora_meandrina_HIv1___Sc0000007:5135149-5136149",145,-24.83,2,20,874,894,18,"61.11%","77.78%","Pocillopora_meandrina_HIv1___RNAseq.g5575.t1",-0.927672082741259,0.0230953264417934,0.698759485874756,"Q4V8V1","Breast cancer metastasis-suppressor 1-like protein-A","Danio rerio (Zebrafish) (Brachydanio rerio)","histone deacetylation [GO:0016575]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of stem cell population maintenance [GO:1902459]","GO:0000122; GO:0016575; GO:0030336; GO:0030512; GO:0042826; GO:0070822; GO:1902455; GO:1902459"
"260",260,"Cluster_1068","Pocillopora_meandrina_HIv1___Sc0000012:5907976-5908976",150,-21.01,2,15,938,959,13,"76.92%","84.62%","Pocillopora_meandrina_HIv1___RNAseq.g9962.t1a",0.929810593848995,0.0220859037276938,0.694660351169505,NA,NA,NA,NA,NA
"266",266,"Cluster_1068","Pocillopora_meandrina_HIv1___Sc0000013:8231368-8232368",163,-26.02,2,17,128,151,17,"82.35%","88.24%","Pocillopora_meandrina_HIv1___RNAseq.g3736.t1",-0.898047575626946,0.0384746455788641,0.760878962620332,NA,NA,NA,NA,NA
"276",276,"Cluster_1068","Pocillopora_meandrina_HIv1___Sc0000015:4542727-4543727",161,-22.13,2,18,948,969,16,"75.00%","87.50%","Pocillopora_meandrina_HIv1___RNAseq.g4470.t1",0.911529929038018,0.0311658930926369,0.736477304549637,"Q9NZJ4","Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29)","Homo sapiens (Human)","negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457]","GO:0005634; GO:0005737; GO:0005739; GO:0006457; GO:0030424; GO:0030425; GO:0030544; GO:0042802; GO:0051087; GO:0070628; GO:0070852; GO:0090084"
"295",295,"Cluster_1068","Pocillopora_meandrina_HIv1___Sc0000018:8112514-8113514",140,-22.83,2,9,791,812,7,"100.00%","100.00%","Pocillopora_meandrina_HIv1___TS.g8592.t1",0.938779898628061,0.0180154908165704,0.674410729954476,NA,NA,NA,NA,NA
"352",352,"Cluster_1080","Pocillopora_meandrina_HIv1___Sc0000010:8572196-8573196",169,-20.95,2,20,462,482,18,"77.78%","94.44%","Pocillopora_meandrina_HIv1___RNAseq.g13529.t1",-0.94794890100126,0.0141435534052206,0.674410729954476,"Q9D7M8","DNA-directed RNA polymerase II subunit RPB4 (RNA polymerase II subunit B4) (DNA-directed RNA polymerase II subunit D)","Mus musculus (Mouse)","mRNA export from nucleus in response to heat stress [GO:0031990]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; positive regulation of translational initiation [GO:0045948]; recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex [GO:0034402]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367]","GO:0000166; GO:0000288; GO:0000932; GO:0005634; GO:0005654; GO:0005665; GO:0005829; GO:0006366; GO:0006367; GO:0016607; GO:0031369; GO:0031990; GO:0034402; GO:0045948"
"358",358,"Cluster_1080","Pocillopora_meandrina_HIv1___Sc0000034:363924-364924",182,-20.44,2,21,323,343,19,"89.47%","94.74%","Pocillopora_meandrina_HIv1___RNAseq.g9265.t1",0.915463997365209,0.0291280470997241,0.726734809168451,NA,NA,NA,NA,NA
"360",360,"Cluster_1080","Pocillopora_meandrina_HIv1___Sc0000044:991014-992014",178,-24.01,2,21,722,742,19,"84.21%","94.74%","Pocillopora_meandrina_HIv1___RNAseq.g4947.t1",-0.881328155386284,0.0481914054721745,0.788202769721945,"Q7TN02","Mediator of RNA polymerase II transcription subunit 26 (Cofactor required for Sp1 transcriptional activation subunit 7) (CRSP complex subunit 7) (Mediator complex subunit 26)","Mus musculus (Mouse)","positive regulation of gene expression [GO:0010628]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]","GO:0003712; GO:0005634; GO:0005654; GO:0006357; GO:0010628; GO:0016592; GO:0032968; GO:0051123; GO:0060261; GO:0070847"
"364",364,"Cluster_1116","Pocillopora_meandrina_HIv1___Sc0000003:7962721-7963721",156,-20.03,2,21,805,824,19,"78.95%","78.95%","Pocillopora_meandrina_HIv1___RNAseq.g15789.t1",-0.88869857361464,0.0438226048704799,0.774662491925395,NA,NA,NA,NA,NA
"367",367,"Cluster_1116","Pocillopora_meandrina_HIv1___Sc0000006:5728068-5729068",171,-23.99,2,21,696,720,22,"77.27%","81.82%","Pocillopora_meandrina_HIv1___TS.g14605.t2",0.896919047723435,0.0391083811405708,0.760878962620332,"Q9C0A0","Contactin-associated protein-like 4 (Cell recognition molecule Caspr4)","Homo sapiens (Human)","cell adhesion [GO:0007155]; regulation of grooming behavior [GO:2000821]; regulation of synaptic transmission, dopaminergic [GO:0032225]; regulation of synaptic transmission, GABAergic [GO:0032228]","GO:0007155; GO:0032225; GO:0032228; GO:0042734; GO:0042995; GO:2000821"
"370",370,"Cluster_1116","Pocillopora_meandrina_HIv1___Sc0000010:499671-500671",157,-20.6,2,21,600,621,20,"70.00%","85.00%","Pocillopora_meandrina_HIv1___RNAseq.g12885.t1",-0.884874533118656,0.0460728881542177,0.781898617866587,NA,NA,NA,NA,NA
"374",374,"Cluster_1116","Pocillopora_meandrina_HIv1___Sc0000013:6288542-6289078",157,-21.61,2,21,283,308,24,"70.83%","75.00%","Pocillopora_meandrina_HIv1___RNAseq.g3552.t1",0.947909268643452,0.0141596244533775,0.674410729954476,NA,NA,NA,NA,NA
"375",375,"Cluster_1116","Pocillopora_meandrina_HIv1___Sc0000015:8335637-8336637",149,-20.6,2,21,954,981,25,"64.00%","76.00%","Pocillopora_meandrina_HIv1___RNAseq.g4733.t1b",0.984268783372301,0.00236292463134709,0.667107103030161,NA,NA,NA,NA,NA
"413",413,"Cluster_1296","Pocillopora_meandrina_HIv1___Sc0000002:9804337-9805337",143,-22.21,2,18,839,859,16,"68.75%","75.00%","Pocillopora_meandrina_HIv1___RNAseq.g7188.t1",-0.941449087059812,0.0168571020246151,0.674410729954476,NA,NA,NA,NA,NA
"423",423,"Cluster_1296","Pocillopora_meandrina_HIv1___Sc0000005:12318449-12319449",150,-20.78,2,21,83,103,19,"68.42%","73.68%","Pocillopora_meandrina_HIv1___RNAseq.g23904.t1",-0.945872618092515,0.0149934490890256,0.674410729954476,NA,NA,NA,NA,NA
"433",433,"Cluster_1296","Pocillopora_meandrina_HIv1___Sc0000006:7354421-7355421",152,-20.29,2,20,257,276,18,"72.22%","77.78%","Pocillopora_meandrina_HIv1___RNAseq.g27467.t1",-0.980394648427,0.00328559858298792,0.667107103030161,"O42412","Thyroxine 5-deiodinase (EC 1.21.99.3) (5DIII) (DIOIII) (Type 3 DI) (Type III iodothyronine deiodinase)","Gallus gallus (Chicken)","hormone biosynthetic process [GO:0042446]; thyroid hormone metabolic process [GO:0042403]","GO:0004800; GO:0005886; GO:0010008; GO:0033798; GO:0042403; GO:0042446"
"444",444,"Cluster_1296","Pocillopora_meandrina_HIv1___Sc0000008:8063371-8064371",147,-21.59,2,19,589,611,19,"73.68%","73.68%","Pocillopora_meandrina_HIv1___RNAseq.g2374.t1",-0.937764994677695,0.0184624632119159,0.677936616642814,NA,NA,NA,NA,NA
"460",460,"Cluster_1296","Pocillopora_meandrina_HIv1___Sc0000015:9271412-9272412",156,-20.76,2,21,905,926,19,"68.42%","73.68%","Pocillopora_meandrina_HIv1___RNAseq.g4840.t1",-0.897961449768791,0.0385228939633405,0.760878962620332,"A2A6A1","G patch domain-containing protein 8","Mus musculus (Mouse)","","GO:0003676; GO:0005634; GO:0046872"
"492",492,"Cluster_1296","Pocillopora_meandrina_HIv1___Sc0000034:2976433-2976835",151,-25.15,2,21,368,393,23,"65.22%","69.57%","Pocillopora_meandrina_HIv1___RNAseq.g9470.t1",-0.93581307375279,0.0193320343366891,0.68529644171199,NA,NA,NA,NA,NA
"497",497,"Cluster_1296","Pocillopora_meandrina_HIv1___Sc0000039:1186485-1187485",160,-25,2,20,765,789,21,"80.95%","80.95%","Pocillopora_meandrina_HIv1___RNAseq.g3965.t1",-0.95853811479899,0.0100713536600541,0.667107103030161,"Q460N5","Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (B aggressive lymphoma protein 2) (Poly [ADP-ribose] polymerase 14) (PARP-14)","Homo sapiens (Human)","innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein poly-ADP-ribosylation [GO:0070212]","GO:0003714; GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0010629; GO:0016020; GO:0016779; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:1902216; GO:1990404"
"498",498,"Cluster_1296","Pocillopora_meandrina_HIv1___Sc0000039:1211573-1212573",160,-25,2,20,766,790,21,"80.95%","80.95%","Pocillopora_meandrina_HIv1___RNAseq.g3966.t1",-0.960835050497104,0.00924937266998503,0.667107103030161,"Q460N5","Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (B aggressive lymphoma protein 2) (Poly [ADP-ribose] polymerase 14) (PARP-14)","Homo sapiens (Human)","innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein poly-ADP-ribosylation [GO:0070212]","GO:0003714; GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0010629; GO:0016020; GO:0016779; GO:0019899; GO:0042531; GO:0042532; GO:0045087; GO:0060336; GO:0070212; GO:0070403; GO:1902216; GO:1990404"
"499",499,"Cluster_1296","Pocillopora_meandrina_HIv1___Sc0000040:2422872-2423872",155,-22.93,2,20,324,345,18,"66.67%","77.78%","Pocillopora_meandrina_HIv1___TS.g15728.t1",-0.88766157913043,0.044429295698789,0.776294186242663,NA,NA,NA,NA,NA
"516",516,"Cluster_1793","Pocillopora_meandrina_HIv1___Sc0000002:6066890-6067890",179,-27.46,2,20,439,459,18,"88.89%","88.89%","Pocillopora_meandrina_HIv1___RNAseq.g6914.t1",-0.920731943787312,0.0264696868151218,0.71428916766521,NA,NA,NA,NA,NA
"521",521,"Cluster_1793","Pocillopora_meandrina_HIv1___Sc0000006:12384354-12385354",191,-31.07,2,20,576,596,18,"94.44%","100.00%","Pocillopora_meandrina_HIv1___RNAseq.g27972.t1",-0.938821380753771,0.017997297530927,0.674410729954476,NA,NA,NA,NA,NA
"569",569,"Cluster_1938","Pocillopora_meandrina_HIv1___Sc0000000:11638378-11639378",157,-20.18,2,22,566,588,20,"65.00%","75.00%","Pocillopora_meandrina_HIv1___RNAseq.g22048.t1a",-0.931929555088538,0.021100218742159,0.687095063784671,NA,NA,NA,NA,NA
"599",599,"Cluster_1938","Pocillopora_meandrina_HIv1___Sc0000001:16450717-16451717",152,-20.98,2,19,979,1000,17,"64.71%","88.24%","Pocillopora_meandrina_HIv1___RNAseq.g20039.t1",-0.931929555088538,0.021100218742159,0.687095063784671,NA,NA,NA,NA,NA
"607",607,"Cluster_1938","Pocillopora_meandrina_HIv1___Sc0000001:3632973-3633973",150,-23.15,2,22,298,320,21,"61.90%","80.95%","Pocillopora_meandrina_HIv1___TS.g28288.t1",-0.931929555088539,0.021100218742159,0.687095063784671,NA,NA,NA,NA,NA
"640",640,"Cluster_1938","Pocillopora_meandrina_HIv1___Sc0000003:15551635-15552635",153,-22.24,2,22,172,192,20,"70.00%","80.00%","Pocillopora_meandrina_HIv1___RNAseq.g16347.t1",-0.916779953336722,0.0284563307217094,0.724029933136918,"Q9VBW3","Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14)","Drosophila melanogaster (Fruit fly)","calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of kinase activity [GO:0033674]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060]","GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0014068; GO:0016339; GO:0033674; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0090303"
"663",663,"Cluster_1938","Pocillopora_meandrina_HIv1___Sc0000004:14512732-14513108",146,-20.35,2,11,289,311,9,"88.89%","100.00%","Pocillopora_meandrina_HIv1___TS.g13098.t1",-0.968690929628852,0.0066189476302874,0.667107103030161,NA,NA,NA,NA,NA
"669",669,"Cluster_1938","Pocillopora_meandrina_HIv1___Sc0000005:10887140-10888140",167,-24.63,2,21,405,428,20,"70.00%","90.00%","Pocillopora_meandrina_HIv1___RNAseq.9397_t",-0.938290343737649,0.0182306508277494,0.67649047138782,"Q58D31","Sorbitol dehydrogenase (SDH) (EC 1.1.1.-) (L-iditol 2-dehydrogenase) (EC 1.1.1.14) (Polyol dehydrogenase) (Xylitol dehydrogenase) (XDH) (EC 1.1.1.9)","Bos taurus (Bovine)","flagellated sperm motility [GO:0030317]; sorbitol catabolic process [GO:0006062]","GO:0003939; GO:0006062; GO:0008270; GO:0030317; GO:0031514; GO:0031966; GO:0046526"
"675",675,"Cluster_1938","Pocillopora_meandrina_HIv1___Sc0000005:13790762-13791762",158,-24,2,15,320,342,13,"84.62%","92.31%","Pocillopora_meandrina_HIv1___TS.g16929.t1",-0.931505175469489,0.021296460478133,0.689082978724957,"Q8IVG5","Sterile alpha motif domain-containing protein 9-like (SAM domain-containing protein 9-like)","Homo sapiens (Human)","","GO:0005737; GO:0005739; GO:0005769"
"684",684,"Cluster_1938","Pocillopora_meandrina_HIv1___Sc0000006:1791386-1792386",164,-22.77,2,22,130,153,21,"66.67%","85.71%","Pocillopora_meandrina_HIv1___RNAseq.g26810.t1",-0.926538810640125,0.0236361348277314,0.698759485874756,NA,NA,NA,NA,NA
"688",688,"Cluster_1938","Pocillopora_meandrina_HIv1___Sc0000006:2535800-2536800",166,-21.65,2,22,225,245,20,"75.00%","85.00%","Pocillopora_meandrina_HIv1___RNAseq.g26939.t1",-0.931929555088539,0.021100218742159,0.687095063784671,NA,NA,NA,NA,NA
"706",706,"Cluster_1938","Pocillopora_meandrina_HIv1___Sc0000007:2144770-2145770",156,-20.26,2,20,400,420,18,"72.22%","83.33%","Pocillopora_meandrina_HIv1___RNAseq.g5308.t1",-0.970702274621538,0.00599331201058183,0.667107103030161,"Q3UJK4","GTP-binding protein 2 (GTP-binding-like protein 2)","Mus musculus (Mouse)","nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; rescue of stalled ribosome [GO:0072344]; translational elongation [GO:0006414]","GO:0003746; GO:0003924; GO:0005525; GO:0006414; GO:0042802; GO:0070966; GO:0072344"
"722",722,"Cluster_1938","Pocillopora_meandrina_HIv1___Sc0000008:5806767-5807767",160,-22.98,2,18,957,981,18,"77.78%","83.33%","Pocillopora_meandrina_HIv1___TS.g4673.t1",-0.913412453415158,0.0301852264600589,0.731630337652041,"A0JMD4","Two pore channel protein 2 (Two pore calcium channel protein 2) (Voltage-dependent calcium channel protein TPC2)","Danio rerio (Zebrafish) (Brachydanio rerio)","calcium-mediated signaling [GO:0019722]; endocytosis involved in viral entry into host cell [GO:0075509]; regulation of ion transmembrane transport [GO:0034765]; regulation of myotome development [GO:2000290]; skeletal myofibril assembly [GO:0014866]; smooth muscle contraction [GO:0006939]; sodium ion transmembrane transport [GO:0035725]","GO:0005245; GO:0005764; GO:0005765; GO:0006939; GO:0014866; GO:0015280; GO:0019722; GO:0031902; GO:0034765; GO:0035725; GO:0042802; GO:0072345; GO:0075509; GO:0080025; GO:0097682; GO:2000290"
"738",738,"Cluster_1938","Pocillopora_meandrina_HIv1___Sc0000010:3600541-3601541",151,-22.03,2,20,787,806,18,"66.67%","83.33%","Pocillopora_meandrina_HIv1___RNAseq.g13248.t1",-0.931929555088539,0.021100218742159,0.687095063784671,NA,NA,NA,NA,NA
"758",758,"Cluster_1938","Pocillopora_meandrina_HIv1___Sc0000012:6753947-6754947",158,-21.74,2,19,302,324,17,"76.47%","76.47%","Pocillopora_meandrina_HIv1___RNAseq.g10013.t1",0.892902407030778,0.0413905055173883,0.765959821806914,NA,NA,NA,NA,NA
"763",763,"Cluster_1938","Pocillopora_meandrina_HIv1___Sc0000012:9867758-9868066",172,-24.23,2,22,274,298,22,"77.27%","81.82%","Pocillopora_meandrina_HIv1___TS.g23752.t1",-0.931929555088538,0.021100218742159,0.687095063784671,NA,NA,NA,NA,NA
"772",772,"Cluster_1938","Pocillopora_meandrina_HIv1___Sc0000013:7635303-7636303",158,-23.46,2,17,792,816,17,"82.35%","88.24%","Pocillopora_meandrina_HIv1___RNAseq.g3677.t1",-0.931929555088539,0.021100218742159,0.687095063784671,NA,NA,NA,NA,NA
"777",777,"Cluster_1938","Pocillopora_meandrina_HIv1___Sc0000014:4140557-4141557",161,-20.67,2,18,934,956,16,"75.00%","87.50%","Pocillopora_meandrina_HIv1___RNAseq.g26199.t1",-0.878424320238951,0.0499483505098944,0.792431097388,"P12716","Actin, cytoplasmic (EC 3.6.4.-) [Cleaved into: Actin, cytoplasmic, intermediate form]","Pisaster ochraceus (Ochre sea star) (Asterias ochracea)","","GO:0005524; GO:0005737; GO:0005856; GO:0016787"
"782",782,"Cluster_1938","Pocillopora_meandrina_HIv1___Sc0000015:8728436-8729436",156,-20.68,2,22,97,120,21,"66.67%","76.19%","Pocillopora_meandrina_HIv1___RNAseq.g4782.t1",-0.962736514933134,0.00858650786786343,0.667107103030161,"P22574","Homeobox protein Hox-B4a (Hox-B4) (Homeobox protein Zf-13)","Danio rerio (Zebrafish) (Brachydanio rerio)","anterior/posterior pattern specification [GO:0009952]; embryonic skeletal system morphogenesis [GO:0048704]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0009952; GO:0048704"
"785",785,"Cluster_1938","Pocillopora_meandrina_HIv1___Sc0000016:1605439-1606439",158,-20.18,2,20,62,85,19,"68.42%","84.21%","Pocillopora_meandrina_HIv1___RNAseq.g11294.t1",-0.931929555088539,0.021100218742159,0.687095063784671,NA,NA,NA,NA,NA
"787",787,"Cluster_1938","Pocillopora_meandrina_HIv1___Sc0000016:1868037-1869037",169,-22.61,2,22,623,645,20,"75.00%","80.00%","Pocillopora_meandrina_HIv1___RNAseq.g11321.t1",-0.946406867222498,0.0147732199935823,0.674410729954476,"Q13443","Disintegrin and metalloproteinase domain-containing protein 9 (ADAM 9) (EC 3.4.24.-) (Cellular disintegrin-related protein) (Meltrin-gamma) (Metalloprotease/disintegrin/cysteine-rich protein 9) (Myeloma cell metalloproteinase)","Homo sapiens (Human)","amyloid precursor protein catabolic process [GO:0042987]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-cell adhesion mediated by integrin [GO:0033631]; cell-matrix adhesion [GO:0007160]; cellular response to lipopolysaccharide [GO:0071222]; integrin-mediated signaling pathway [GO:0007229]; keratinocyte differentiation [GO:0030216]; membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; monocyte activation [GO:0042117]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of macrophage fusion [GO:0034241]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of protein secretion [GO:0050714]; protein processing [GO:0016485]; response to calcium ion [GO:0051592]; response to glucocorticoid [GO:0051384]; response to hydrogen peroxide [GO:0042542]; response to manganese ion [GO:0010042]; response to tumor necrosis factor [GO:0034612]; transforming growth factor beta receptor signaling pathway [GO:0007179]","GO:0004222; GO:0005080; GO:0005178; GO:0005518; GO:0005615; GO:0005925; GO:0006509; GO:0007155; GO:0007160; GO:0007179; GO:0007229; GO:0008237; GO:0009897; GO:0009986; GO:0010042; GO:0016477; GO:0016485; GO:0017124; GO:0030216; GO:0030335; GO:0031293; GO:0033627; GO:0033630; GO:0033631; GO:0034241; GO:0034612; GO:0042117; GO:0042542; GO:0042987; GO:0043236; GO:0043406; GO:0046872; GO:0050714; GO:0051044; GO:0051384; GO:0051549; GO:0051592; GO:0070062; GO:0071222; GO:1902945"
"789",789,"Cluster_1938","Pocillopora_meandrina_HIv1___Sc0000016:1928880-1929880",169,-22.61,2,22,627,649,20,"75.00%","80.00%","Pocillopora_meandrina_HIv1___TS.g7439.t1",-0.944571525282684,0.0155342072637159,0.674410729954476,"Q13443","Disintegrin and metalloproteinase domain-containing protein 9 (ADAM 9) (EC 3.4.24.-) (Cellular disintegrin-related protein) (Meltrin-gamma) (Metalloprotease/disintegrin/cysteine-rich protein 9) (Myeloma cell metalloproteinase)","Homo sapiens (Human)","amyloid precursor protein catabolic process [GO:0042987]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-cell adhesion mediated by integrin [GO:0033631]; cell-matrix adhesion [GO:0007160]; cellular response to lipopolysaccharide [GO:0071222]; integrin-mediated signaling pathway [GO:0007229]; keratinocyte differentiation [GO:0030216]; membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; monocyte activation [GO:0042117]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of macrophage fusion [GO:0034241]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of protein secretion [GO:0050714]; protein processing [GO:0016485]; response to calcium ion [GO:0051592]; response to glucocorticoid [GO:0051384]; response to hydrogen peroxide [GO:0042542]; response to manganese ion [GO:0010042]; response to tumor necrosis factor [GO:0034612]; transforming growth factor beta receptor signaling pathway [GO:0007179]","GO:0004222; GO:0005080; GO:0005178; GO:0005518; GO:0005615; GO:0005925; GO:0006509; GO:0007155; GO:0007160; GO:0007179; GO:0007229; GO:0008237; GO:0009897; GO:0009986; GO:0010042; GO:0016477; GO:0016485; GO:0017124; GO:0030216; GO:0030335; GO:0031293; GO:0033627; GO:0033630; GO:0033631; GO:0034241; GO:0034612; GO:0042117; GO:0042542; GO:0042987; GO:0043236; GO:0043406; GO:0046872; GO:0050714; GO:0051044; GO:0051384; GO:0051549; GO:0051592; GO:0070062; GO:0071222; GO:1902945"
"799",799,"Cluster_1938","Pocillopora_meandrina_HIv1___Sc0000016:8180449-8181449",157,-24.25,2,18,700,722,16,"68.75%","87.50%","Pocillopora_meandrina_HIv1___RNAseq.g11726.t1",-0.889126369408088,0.0435730964984779,0.773715073543974,NA,NA,NA,NA,NA
"802",802,"Cluster_1938","Pocillopora_meandrina_HIv1___Sc0000017:2932301-2933301",159,-21.78,2,22,236,263,25,"64.00%","80.00%","Pocillopora_meandrina_HIv1___TS.g6338.t1",-0.944201856340828,0.0156889832429303,0.674410729954476,"P0C6Y7","Histone-lysine N-methyltransferase PRDM9 (PR domain zinc finger protein 9) (PR domain-containing protein 9) (Protein-lysine N-methyltransferase PRDM9) (EC 2.1.1.-) ([histone H3]-lysine36 N-trimethyltransferase PRDM9) (EC 2.1.1.359) ([histone H3]-lysine4 N-trimethyltransferase PRDM9) (EC 2.1.1.354) ([histone H3]-lysine9 N-trimethyltransferase PRDM9) (EC 2.1.1.355) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.361)","Rattus norvegicus (Rat)","chromatin organization [GO:0006325]; double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; histone H3-K4 dimethylation [GO:0044648]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 monomethylation [GO:0097692]; histone H3-K4 trimethylation [GO:0080182]; histone H3-K9 methylation [GO:0051567]; histone lysine methylation [GO:0034968]; histone methylation [GO:0016571]; histone modification [GO:0016570]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; meiosis I [GO:0007127]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; positive regulation of fertilization [GO:1905516]; positive regulation of histone H3-K36 trimethylation [GO:2001255]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein methylation [GO:0006479]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283]","GO:0000785; GO:0000976; GO:0005634; GO:0006311; GO:0006325; GO:0006479; GO:0007127; GO:0007129; GO:0007283; GO:0007292; GO:0010468; GO:0010844; GO:0010845; GO:0016570; GO:0016571; GO:0018024; GO:0034968; GO:0042800; GO:0042803; GO:0043066; GO:0043565; GO:0044648; GO:0045944; GO:0046872; GO:0046975; GO:0048232; GO:0051567; GO:0051568; GO:0060903; GO:0080182; GO:0097198; GO:0097676; GO:0097692; GO:0140941; GO:0140944; GO:0140949; GO:0140955; GO:1905516; GO:1990918; GO:2001255"
"809",809,"Cluster_1938","Pocillopora_meandrina_HIv1___Sc0000017:7258870-7259581",159,-21.99,2,22,308,333,23,"65.22%","82.61%","Pocillopora_meandrina_HIv1___RNAseq.g29556.t1b",-0.944211987845358,0.015684734646653,0.674410729954476,"P04323","Retrovirus-related Pol polyprotein from transposon 17.6 [Includes: Protease (EC 3.4.23.-); Reverse transcriptase (EC 2.7.7.49); Endonuclease]","Drosophila melanogaster (Fruit fly)","DNA integration [GO:0015074]; proteolysis [GO:0006508]","GO:0003676; GO:0003887; GO:0003964; GO:0004190; GO:0004519; GO:0006508; GO:0015074; GO:0042575"
"828",828,"Cluster_1938","Pocillopora_meandrina_HIv1___Sc0000019:6437238-6437948",157,-22.48,2,18,465,487,16,"68.75%","87.50%","Pocillopora_meandrina_HIv1___RNAseq.g18403.t1a",-0.931929555088538,0.021100218742159,0.687095063784671,NA,NA,NA,NA,NA
"846",846,"Cluster_1938","Pocillopora_meandrina_HIv1___Sc0000022:3597734-3598734",161,-22.51,2,20,491,512,18,"77.78%","83.33%","Pocillopora_meandrina_HIv1___RNAseq.g3054.t1",-0.933913944141024,0.0201904506483588,0.687095063784671,"Q9Z2Z6","Mitochondrial carnitine/acylcarnitine carrier protein (Carnitine/acylcarnitine translocase) (CAC) (CACT) (mCAC) (Solute carrier family 25 member 20)","Mus musculus (Mouse)","carnitine transmembrane transport [GO:1902603]; in utero embryonic development [GO:0001701]; lipid transport [GO:0006869]; mitochondrial transport [GO:0006839]","GO:0001701; GO:0005739; GO:0005740; GO:0005743; GO:0005829; GO:0006839; GO:0006869; GO:0015227; GO:0022857; GO:1902603"
"857",857,"Cluster_1938","Pocillopora_meandrina_HIv1___Sc0000024:4268761-4269761",167,-27.07,2,18,556,577,16,"87.50%","93.75%","Pocillopora_meandrina_HIv1___RNAseq.g14836.t1",-0.900453064384724,0.0371348962993556,0.760640681469892,NA,NA,NA,NA,NA
"890",890,"Cluster_1938","Pocillopora_meandrina_HIv1___Sc0000030:732923-733923",156,-23.13,2,22,555,580,23,"60.87%","78.26%","Pocillopora_meandrina_HIv1___RNAseq.g25459.t1",-0.907256647839746,0.033428913285408,0.745127957735035,NA,NA,NA,NA,NA
"895",895,"Cluster_1938","Pocillopora_meandrina_HIv1___Sc0000032:1354641-1355641",157,-22.65,2,20,143,164,18,"72.22%","83.33%","Pocillopora_meandrina_HIv1___RNAseq.g30111.t1",-0.931929555088538,0.0211002187421591,0.687095063784671,"B8V7P3","Putative carbonic anhydrase (EC 4.2.1.1) (Carbonate dehydratase)","Acropora millepora (Staghorn coral) (Heteropora millepora)","","GO:0004089; GO:0005576; GO:0008270"
"928",928,"Cluster_1952","Pocillopora_meandrina_HIv1___Sc0000000:4201063-4202063",164,-22.54,2,21,470,491,19,"68.42%","84.21%","Pocillopora_meandrina_HIv1___TS.g26105.t1",-0.956420695574493,0.0108491278448096,0.669105275336596,NA,NA,NA,NA,NA
"929",929,"Cluster_1952","Pocillopora_meandrina_HIv1___Sc0000000:6034797-6035797",159,-20.96,2,21,339,361,20,"70.00%","80.00%","Pocillopora_meandrina_HIv1___RNAseq.g21547.t1",-0.906214923782366,0.0339882392340703,0.747496681093633,NA,NA,NA,NA,NA
"944",944,"Cluster_1952","Pocillopora_meandrina_HIv1___Sc0000002:19528872-19529872",160,-21.18,2,21,9,30,19,"68.42%","78.95%","Pocillopora_meandrina_HIv1___RNAseq.g8039.t1",-0.880300650582873,0.0488108158227748,0.789465680505196,"P50572","Gamma-aminobutyric acid receptor subunit rho-1 (GABA(A) receptor subunit rho-1) (GABA(C) receptor)","Rattus norvegicus (Rat)","chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; modulation of chemical synaptic transmission [GO:0050804]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; regulation of postsynaptic membrane potential [GO:0060078]; signal transduction [GO:0007165]; visual perception [GO:0007601]","GO:0004890; GO:0005231; GO:0005254; GO:0005886; GO:0007165; GO:0007268; GO:0007601; GO:0016917; GO:0019904; GO:0030594; GO:0034220; GO:0034707; GO:0042391; GO:0042734; GO:0042802; GO:0043005; GO:0044877; GO:0045202; GO:0045211; GO:0050804; GO:0050877; GO:0060078; GO:0098978; GO:0098982; GO:0099507; GO:1902476; GO:1902711; GO:1904315"
"996",996,"Cluster_1952","Pocillopora_meandrina_HIv1___Sc0000012:9634905-9635905",160,-23.69,2,21,73,92,19,"78.95%","84.21%","Pocillopora_meandrina_HIv1___RNAseq.g10194.t1",-0.942066678237258,0.0165926622500592,0.674410729954476,"P0C5Y8","Alsin (Amyotrophic lateral sclerosis 2 protein homolog)","Rattus norvegicus (Rat)","axonogenesis [GO:0007409]; behavioral fear response [GO:0001662]; cell death [GO:0008219]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; in utero embryonic development [GO:0001701]; locomotory behavior [GO:0007626]; lysosomal transport [GO:0007041]; neuromuscular junction development [GO:0007528]; neuron projection morphogenesis [GO:0048812]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein kinase activity [GO:0045860]; protein homooligomerization [GO:0051260]; protein localization [GO:0008104]; Rac protein signal transduction [GO:0016601]; receptor recycling [GO:0001881]; regulation of endosome size [GO:0051036]; regulation of GTPase activity [GO:0043087]; response to oxidative stress [GO:0006979]; synaptic transmission, glutamatergic [GO:0035249]; vesicle organization [GO:0016050]","GO:0001662; GO:0001701; GO:0001726; GO:0001881; GO:0005085; GO:0005096; GO:0005634; GO:0005737; GO:0005769; GO:0005813; GO:0005829; GO:0006979; GO:0007032; GO:0007041; GO:0007409; GO:0007528; GO:0007626; GO:0008104; GO:0008219; GO:0014069; GO:0016020; GO:0016050; GO:0016197; GO:0016601; GO:0030027; GO:0030424; GO:0030425; GO:0030426; GO:0031267; GO:0031982; GO:0032991; GO:0035249; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0043087; GO:0043197; GO:0043231; GO:0043539; GO:0043547; GO:0045202; GO:0045860; GO:0048812; GO:0051036; GO:0051260"
"1000",1000,"Cluster_1952","Pocillopora_meandrina_HIv1___Sc0000014:243163-244163",159,-20.09,2,20,27,48,18,"72.22%","77.78%","Pocillopora_meandrina_HIv1___RNAseq.g25844.t1",0.993115846217196,0.000684952936472363,0.667107103030161,NA,NA,NA,NA,NA
"1036",1036,"Cluster_1952","Pocillopora_meandrina_HIv1___Sc0000028:4140845-4141845",170,-26.44,2,21,948,968,19,"84.21%","84.21%","Pocillopora_meandrina_HIv1___RNAseq.g1120.t1",-0.904967505976228,0.0346619015642873,0.751013846340777,NA,NA,NA,NA,NA
"1069",1069,"Cluster_1953","Pocillopora_meandrina_HIv1___Sc0000000:4901969-4902969",157,-21.29,2,19,396,419,19,"73.68%","78.95%","Pocillopora_meandrina_HIv1___TS.g26164.t1",0.90781138708514,0.033132275840799,0.744196486865969,"P83941","Elongin-C (EloC) (Elongin 15 kDa subunit) (RNA polymerase II transcription factor SIII subunit C) (SIII p15) (Stromal membrane-associated protein SMAP1B homolog) (Transcription elongation factor B polypeptide 1)","Rattus norvegicus (Rat)","positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; protein ubiquitination [GO:0016567]; transcription initiation at RNA polymerase II promoter [GO:0006367]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0001222; GO:0006367; GO:0006511; GO:0016567; GO:0030674; GO:0030891; GO:0031466; GO:0032968; GO:0044877; GO:0070449"
"1141",1141,"Cluster_1953","Pocillopora_meandrina_HIv1___Sc0000019:2373638-2374638",154,-21.08,2,21,464,488,22,"72.73%","72.73%","Pocillopora_meandrina_HIv1___RNAseq.g18085.t1",0.959291997233672,0.00979904509164128,0.667107103030161,NA,NA,NA,NA,NA
"1171",1171,"Cluster_1953","Pocillopora_meandrina_HIv1___Sc0000042:238068-239068",163,-23.64,2,20,182,203,18,"66.67%","88.89%","Pocillopora_meandrina_HIv1___RNAseq.g14958.t1",0.927936814689763,0.0229695778538617,0.698759485874756,"Q66JB6","Ubiquitin carboxyl-terminal hydrolase BAP1 (EC 3.4.19.12) (BRCA1-associated protein 1)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","chromatin organization [GO:0006325]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; negative regulation of DNA-templated transcription [GO:0045892]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0001558; GO:0003682; GO:0004843; GO:0005634; GO:0005737; GO:0006325; GO:0006511; GO:0016579; GO:0035517; GO:0035522; GO:0045892; GO:0051726; GO:0071108"
"1262",1262,"Cluster_21","Pocillopora_meandrina_HIv1___Sc0000013:1072924-1073924",160,-23.21,2,19,961,981,17,"82.35%","82.35%","Pocillopora_meandrina_HIv1___RNAseq.g3315.t1",-0.922399900875207,0.0256452206898009,0.709465579574695,"Q14416","Metabotropic glutamate receptor 2 (mGluR2)","Homo sapiens (Human)","behavioral response to nicotine [GO:0035095]; cellular glutamate homeostasis [GO:0090461]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; glutamate secretion [GO:0014047]; long-term synaptic depression [GO:0060292]; negative regulation of adenylate cyclase activity [GO:0007194]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of dopamine secretion [GO:0014059]; regulation of glutamate secretion [GO:0014048]; regulation of protein kinase B signaling [GO:0051896]; regulation of response to drug [GO:2001023]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to cocaine [GO:0042220]","GO:0001640; GO:0001641; GO:0004930; GO:0005246; GO:0005886; GO:0007194; GO:0007216; GO:0007268; GO:0008066; GO:0010467; GO:0014047; GO:0014048; GO:0014059; GO:0030424; GO:0030425; GO:0035095; GO:0042220; GO:0042734; GO:0051896; GO:0051966; GO:0060292; GO:0090461; GO:0097110; GO:0097449; GO:0098978; GO:0099171; GO:2001023"
"1337",1337,"Cluster_21","Pocillopora_meandrina_HIv1___xfSc0000892:5380-6380",165,-23.58,2,18,617,638,16,"81.25%","87.50%","Pocillopora_meandrina_HIv1___TS.g23771.t1",-0.931388586488911,0.0213504765008666,0.68937522880379,NA,NA,NA,NA,NA
"1354",1354,"Cluster_2793","Pocillopora_meandrina_HIv1___Sc0000004:9069165-9070165",165,-21.33,2,20,115,139,22,"77.27%","81.82%","Pocillopora_meandrina_HIv1___TS.g12745.t1",-0.920290111823724,0.0266894874494484,0.715145721498623,NA,NA,NA,NA,NA
"1379",1379,"Cluster_2793","Pocillopora_meandrina_HIv1___Sc0000024:3835414-3836414",171,-20.15,2,17,31,52,16,"93.75%","93.75%","Pocillopora_meandrina_HIv1___TS.g3943.t1",-0.920634899767106,0.0265179136510768,0.714425626614317,NA,NA,NA,NA,NA
"1432",1432,"Cluster_2837","Pocillopora_meandrina_HIv1___Sc0000011:9802376-9803376",162,-24.37,2,21,447,473,24,"75.00%","75.00%","Pocillopora_meandrina_HIv1___RNAseq.g9041.t1a",-0.88286285877885,0.047270914120223,0.785541658778615,NA,NA,NA,NA,NA
"1435",1435,"Cluster_2837","Pocillopora_meandrina_HIv1___Sc0000015:156034-157034",155,-21.52,2,21,564,586,20,"70.00%","75.00%","Pocillopora_meandrina_HIv1___RNAseq.g4104.t1",0.878873396965531,0.0496753425334264,0.79195052126402,"A0A0R4IXF6","Histone acetyltransferase KAT2A (EC 2.3.1.48) (Histone glutaryltransferase KAT2A) (EC 2.3.1.-) (Histone succinyltransferase KAT2A) (EC 2.3.1.-) (Lysine acetyltransferase 2A)","Danio rerio (Zebrafish) (Brachydanio rerio)","bone morphogenesis [GO:0060349]; chromatin remodeling [GO:0006338]; heart development [GO:0007507]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone succinylation [GO:0106077]; internal peptidyl-lysine acetylation [GO:0018393]; limb development [GO:0060173]; long-term memory [GO:0007616]; peptidyl-lysine glutarylation [GO:0106227]; positive regulation of cytokine production [GO:0001819]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of bone development [GO:1903010]; regulation of cartilage development [GO:0061035]; regulation of regulatory T cell differentiation [GO:0045589]; regulation of synaptic plasticity [GO:0048167]; regulation of T cell activation [GO:0050863]","GO:0000123; GO:0001819; GO:0003682; GO:0003713; GO:0004402; GO:0005634; GO:0005737; GO:0005813; GO:0006338; GO:0007507; GO:0007616; GO:0010484; GO:0018393; GO:0043966; GO:0043992; GO:0044154; GO:0045589; GO:0045893; GO:0045944; GO:0048167; GO:0050863; GO:0060173; GO:0060349; GO:0061035; GO:0061733; GO:0106077; GO:0106078; GO:0106227; GO:0106229; GO:0140672; GO:1903010"
"1495",1495,"Cluster_2839","Pocillopora_meandrina_HIv1___Sc0000024:2840611-2841611",156,-22.32,2,14,299,321,13,"92.31%","92.31%","Pocillopora_meandrina_HIv1___RNAseq.g14712.t1",-0.922440996057499,0.0256250138290092,0.709465579574695,NA,NA,NA,NA,NA
"1515",1515,"Cluster_2859","Pocillopora_meandrina_HIv1___Sc0000006:6949926-6950926",161,-20.48,2,18,561,582,16,"75.00%","87.50%","Pocillopora_meandrina_HIv1___RNAseq.g27416.t1",0.963538372728917,0.0083118618353658,0.667107103030161,"P56812","Programmed cell death protein 5 (TF-1 cell apoptosis-related protein 19) (Protein TFAR19)","Mus musculus (Mouse)","apoptotic process [GO:0006915]; cellular response to transforming growth factor beta stimulus [GO:0071560]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chaperone-mediated protein folding [GO:1903645]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of protein insertion into mitochondrial outer membrane [GO:1903638]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]","GO:0003677; GO:0005634; GO:0005737; GO:0005829; GO:0006915; GO:0008201; GO:0008285; GO:0010628; GO:0010698; GO:0043065; GO:0043280; GO:0048487; GO:0071560; GO:0090200; GO:1903638; GO:1903645"
"1520",1520,"Cluster_2859","Pocillopora_meandrina_HIv1___Sc0000008:2500072-2501072",167,-21.56,2,16,79,100,14,"85.71%","100.00%","Pocillopora_meandrina_HIv1___RNAseq.g1865.t1",0.914699191077989,0.0295207424194165,0.728771564530352,NA,NA,NA,NA,NA
"1527",1527,"Cluster_2859","Pocillopora_meandrina_HIv1___Sc0000014:6071432-6072432",172,-22.63,2,21,52,73,19,"78.95%","84.21%","Pocillopora_meandrina_HIv1___RNAseq.g26353.t1",-0.988707250891135,0.00143812405780436,0.667107103030161,"P02711","Acetylcholine receptor subunit alpha","Torpedo marmorata (Marbled electric ray)","acetylcholine receptor signaling pathway [GO:0095500]","GO:0004888; GO:0005892; GO:0022848; GO:0045202; GO:0045211; GO:0095500"
"1535",1535,"Cluster_2859","Pocillopora_meandrina_HIv1___Sc0000029:406845-407845",165,-20.44,2,21,804,828,22,"77.27%","86.36%","Pocillopora_meandrina_HIv1___RNAseq.g10251.t1",0.901167799871621,0.0367397502842216,0.759048365829669,"O89110","Caspase-8 (CASP-8) (EC 3.4.22.61) [Cleaved into: Caspase-8 subunit p18; Caspase-8 subunit p10]","Mus musculus (Mouse)","activation of cysteine-type endopeptidase activity [GO:0097202]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cardiac muscle tissue development [GO:0048738]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; heart development [GO:0007507]; hepatocyte apoptotic process [GO:0097284]; macrophage differentiation [GO:0030225]; necroptotic process [GO:0070266]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of necroptotic process [GO:0060546]; neural tube formation [GO:0001841]; positive regulation of apoptotic process [GO:0043065]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of neuron death [GO:1901216]; positive regulation of proteolysis [GO:0045862]; protein processing [GO:0016485]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; pyroptosis [GO:0070269]; regulation of apoptotic signaling pathway [GO:2001233]; regulation of cytokine production [GO:0001817]; regulation of innate immune response [GO:0045088]; regulation of thymocyte apoptotic process [GO:0070243]; response to ethanol [GO:0045471]; response to tumor necrosis factor [GO:0034612]; self proteolysis [GO:0097264]; TRAIL-activated apoptotic signaling pathway [GO:0036462]","GO:0001525; GO:0001817; GO:0001841; GO:0004175; GO:0004197; GO:0005123; GO:0005164; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006508; GO:0006915; GO:0006919; GO:0007507; GO:0008233; GO:0008303; GO:0008625; GO:0016485; GO:0030225; GO:0030690; GO:0031264; GO:0031265; GO:0031625; GO:0032731; GO:0032991; GO:0034612; GO:0035877; GO:0036462; GO:0042802; GO:0043005; GO:0043065; GO:0043123; GO:0043124; GO:0044297; GO:0044877; GO:0045088; GO:0045121; GO:0045471; GO:0045651; GO:0045862; GO:0048738; GO:0051603; GO:0060546; GO:0070243; GO:0070266; GO:0070269; GO:0097110; GO:0097153; GO:0097190; GO:0097191; GO:0097194; GO:0097199; GO:0097200; GO:0097202; GO:0097264; GO:0097284; GO:0097342; GO:1901216; GO:2001233; GO:2001238"
"1537",1537,"Cluster_2859","Pocillopora_meandrina_HIv1___Sc0000029:797819-798819",165,-20.44,2,21,819,843,22,"77.27%","86.36%","Pocillopora_meandrina_HIv1___TS.g13692.t1",0.931470852795496,0.0213123576737912,0.689152887404762,"F1NV61","Caspase-7 (CASP-7) (EC 3.4.22.60) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11]","Gallus gallus (Chicken)","apoptotic process [GO:0006915]; defense response to bacterium [GO:0042742]; execution phase of apoptosis [GO:0097194]; lymphocyte apoptotic process [GO:0070227]; positive regulation of plasma membrane repair [GO:1905686]; proteolysis [GO:0006508]","GO:0003723; GO:0004190; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0042742; GO:0070227; GO:0097153; GO:0097194; GO:0097200; GO:1905686"
"1552",1552,"Cluster_2973","Pocillopora_meandrina_HIv1___Sc0000000:6480263-6481024",166,-20.46,2,21,388,411,21,"76.19%","85.71%","Pocillopora_meandrina_HIv1___RNAseq.g21594.t1",0.882639999046593,0.0474042330985626,0.785950810551761,"Q6GVH4","Gametogenetin-binding protein 2 (Protein ZNF403)","Gallus gallus (Chicken)","cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]","GO:0005634; GO:0005737; GO:0007283; GO:0030154"
"1561",1561,"Cluster_2973","Pocillopora_meandrina_HIv1___Sc0000001:18921310-18922310",148,-21.26,2,21,56,75,19,"57.89%","89.47%","Pocillopora_meandrina_HIv1___RNAseq.g20276.t1",-0.975576127898506,0.00456518245332873,0.667107103030161,"Q3SZV5","Proteasome maturation protein (Proteassemblin)","Bos taurus (Bovine)","proteasome assembly [GO:0043248]","GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0016020; GO:0043248"
"1587",1587,"Cluster_2973","Pocillopora_meandrina_HIv1___Sc0000003:9983942-9984942",149,-20.94,2,20,96,116,18,"61.11%","83.33%","Pocillopora_meandrina_HIv1___RNAseq.g15953.t1",0.951315168814306,0.0128005069263182,0.674410729954476,NA,NA,NA,NA,NA
"1594",1594,"Cluster_2973","Pocillopora_meandrina_HIv1___Sc0000004:7283519-7284519",150,-21.31,2,21,895,915,19,"63.16%","78.95%","Pocillopora_meandrina_HIv1___RNAseq.g24675.t1",0.96863318658699,0.0066372088836617,0.667107103030161,NA,NA,NA,NA,NA
"1598",1598,"Cluster_2973","Pocillopora_meandrina_HIv1___Sc0000005:10398511-10399511",167,-26.47,2,17,334,356,16,"87.50%","93.75%","Pocillopora_meandrina_HIv1___TS.g16589.t1",0.963434717146151,0.0083471999364006,0.667107103030161,"Q640N2","ADP-ribosylation factor-like protein 13B (ADP-ribosylation factor-like protein 2-like 1) (ARL2-like protein 1) (Protein hennin)","Mus musculus (Mouse)","cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; formation of radial glial scaffolds [GO:0021943]; heart looping [GO:0001947]; interneuron migration from the subpallium to the cortex [GO:0021830]; left/right axis specification [GO:0070986]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; receptor localization to non-motile cilium [GO:0097500]; response to lithium ion [GO:0010226]; smoothened signaling pathway [GO:0007224]","GO:0001947; GO:0003924; GO:0005525; GO:0005829; GO:0005929; GO:0005930; GO:0007224; GO:0007368; GO:0009953; GO:0010226; GO:0021532; GO:0021830; GO:0021943; GO:0031514; GO:0060170; GO:0060271; GO:0070986; GO:0097500; GO:0097730; GO:1905515"
"1600",1600,"Cluster_2973","Pocillopora_meandrina_HIv1___Sc0000005:3594028-3594478",167,-22.28,2,21,212,234,20,"75.00%","85.00%","Pocillopora_meandrina_HIv1___RNAseq.g23169.t1",0.972424333140864,0.00547417035177573,0.667107103030161,NA,NA,NA,NA,NA
"1601",1601,"Cluster_2973","Pocillopora_meandrina_HIv1___Sc0000005:4970491-4971491",162,-23.76,2,17,771,791,15,"86.67%","93.33%","Pocillopora_meandrina_HIv1___TS.g16193.t1",0.951315168814306,0.0128005069263182,0.674410729954476,NA,NA,NA,NA,NA
"1602",1602,"Cluster_2973","Pocillopora_meandrina_HIv1___Sc0000005:629481-630481",167,-26.47,2,17,913,935,16,"87.50%","93.75%","Pocillopora_meandrina_HIv1___RNAseq.g22915.t2",0.954719422617249,0.0114876143703483,0.674410729954476,NA,NA,NA,NA,NA
"1618",1618,"Cluster_2973","Pocillopora_meandrina_HIv1___Sc0000007:3911176-3912176",150,-20.52,2,21,682,702,19,"57.89%","84.21%","Pocillopora_meandrina_HIv1___RNAseq.g5433.t1",0.92574399213822,0.0240178348072135,0.699320062567188,NA,NA,NA,NA,NA
"1623",1623,"Cluster_2973","Pocillopora_meandrina_HIv1___Sc0000008:1541641-1542503",163,-23.28,2,21,539,561,20,"70.00%","85.00%","Pocillopora_meandrina_HIv1___RNAseq.g1748.t1",-0.892055341598889,0.041877012620314,0.767524380043074,"Q9YGD2","Succinate--CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial (EC 6.2.1.4) (EC 6.2.1.5) (Succinyl-CoA synthetase subunit alpha) (SCS-alpha)","Columba livia (Rock dove)","tricarboxylic acid cycle [GO:0006099]","GO:0000166; GO:0004775; GO:0004776; GO:0005739; GO:0006099"
"1635",1635,"Cluster_2973","Pocillopora_meandrina_HIv1___Sc0000010:2217146-2218146",162,-23.27,2,21,560,584,22,"68.18%","86.36%","Pocillopora_meandrina_HIv1___RNAseq.g13109.t1",-0.907134859532603,0.0334941507784414,0.745358467733634,NA,NA,NA,NA,NA
"1638",1638,"Cluster_2973","Pocillopora_meandrina_HIv1___Sc0000010:5552468-5553468",155,-20.21,2,18,715,735,16,"75.00%","87.50%","Pocillopora_meandrina_HIv1___RNAseq.g13373.t1",-0.882998992568619,0.0471895347484374,0.785225002236628,"Q6RFZ7","Pleckstrin homology domain-containing family G member 5 (PH domain-containing family G member 5) (Neuronal RhoA GEF protein) (Transcript highly enriched in cortex and hippocampus)","Rattus norvegicus (Rat)","endothelial cell chemotaxis [GO:0035767]; endothelial cell migration [GO:0043542]; regulation of protein catabolic process at presynapse, modulating synaptic transmission [GO:0099575]; regulation protein catabolic process at presynapse [GO:0140251]; Rho protein signal transduction [GO:0007266]","GO:0005085; GO:0005737; GO:0005886; GO:0005911; GO:0007266; GO:0030027; GO:0030139; GO:0030424; GO:0035767; GO:0043542; GO:0045202; GO:0048471; GO:0098793; GO:0099575; GO:0140251"
"1641",1641,"Cluster_2973","Pocillopora_meandrina_HIv1___Sc0000011:2638529-2639529",158,-20.47,2,18,374,393,16,"81.25%","87.50%","Pocillopora_meandrina_HIv1___RNAseq.g8391.t1",-0.923798036149128,0.0249606400798026,0.705534639418762,"O77735","Secretory carrier-associated membrane protein 1 (Secretory carrier membrane protein 1)","Sus scrofa (Pig)","establishment of localization in cell [GO:0051649]; exocytosis [GO:0006887]; protein transport [GO:0015031]","GO:0005802; GO:0006887; GO:0015031; GO:0016020; GO:0030672; GO:0032588; GO:0042589; GO:0051649; GO:0055038"
"1643",1643,"Cluster_2973","Pocillopora_meandrina_HIv1___Sc0000011:8216236-8217236",161,-22.95,2,21,87,108,20,"70.00%","90.00%","Pocillopora_meandrina_HIv1___RNAseq.g8879.t1",0.951315168814306,0.0128005069263181,0.674410729954476,NA,NA,NA,NA,NA
"1646",1646,"Cluster_2973","Pocillopora_meandrina_HIv1___Sc0000012:3169077-3170077",151,-21.22,2,20,973,994,18,"61.11%","77.78%","Pocillopora_meandrina_HIv1___RNAseq.g9764.t1",0.951174707666104,0.0128556679152454,0.674410729954476,NA,NA,NA,NA,NA
"1660",1660,"Cluster_2973","Pocillopora_meandrina_HIv1___Sc0000014:5988757-5989757",161,-22.19,2,21,584,605,20,"75.00%","85.00%","Pocillopora_meandrina_HIv1___RNAseq.g26343.t1",0.968235901601172,0.00676329813132959,0.667107103030161,NA,NA,NA,NA,NA
"1665",1665,"Cluster_2973","Pocillopora_meandrina_HIv1___Sc0000014:8130886-8131886",158,-20.44,2,20,740,762,19,"73.68%","78.95%","Pocillopora_meandrina_HIv1___RNAseq.g26540.t1",0.896358056492014,0.0394246363024036,0.760878962620332,"P55115","Zinc metalloproteinase nas-15 (EC 3.4.24.-) (Nematode astacin 15)","Caenorhabditis elegans","proteolysis [GO:0006508]","GO:0004222; GO:0005576; GO:0006508; GO:0008270"
"1673",1673,"Cluster_2973","Pocillopora_meandrina_HIv1___Sc0000015:800986-801986",160,-22.85,2,21,945,966,19,"52.63%","94.74%","Pocillopora_meandrina_HIv1___TS.g21578.t1",0.972633545720529,0.00541216244821857,0.667107103030161,NA,NA,NA,NA,NA
"1694",1694,"Cluster_2973","Pocillopora_meandrina_HIv1___Sc0000019:2648750-2649750",165,-21,2,20,253,273,18,"77.78%","88.89%","Pocillopora_meandrina_HIv1___RNAseq.g18119.t1",0.883451160191259,0.0469195523731773,0.784480035486724,NA,NA,NA,NA,NA
"1699",1699,"Cluster_2973","Pocillopora_meandrina_HIv1___Sc0000021:1087298-1088298",153,-20.94,2,21,56,82,24,"70.83%","75.00%","Pocillopora_meandrina_HIv1___RNAseq.g10665.t1",-0.973093753418005,0.00527658516879749,0.667107103030161,"Q54271","Phosphonopyruvate decarboxylase (EC 4.1.1.82)","Streptomyces hygroscopicus","antibiotic biosynthetic process [GO:0017000]; organic phosphonate biosynthetic process [GO:0032923]","GO:0000287; GO:0017000; GO:0030976; GO:0032923; GO:0033980"
"1705",1705,"Cluster_2973","Pocillopora_meandrina_HIv1___Sc0000023:2511542-2512542",153,-20.77,2,21,812,831,19,"57.89%","89.47%","Pocillopora_meandrina_HIv1___RNAseq.g17627.t1",-0.927717262065728,0.0230738504058418,0.698759485874756,"P10746","Uroporphyrinogen-III synthase (UROIIIS) (UROS) (EC 4.2.1.75) (Hydroxymethylbilane hydrolyase [cyclizing]) (Uroporphyrinogen-III cosynthase)","Homo sapiens (Human)","cellular response to amine stimulus [GO:0071418]; cellular response to arsenic-containing substance [GO:0071243]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to antibiotic [GO:0046677]; response to platinum ion [GO:0070541]; uroporphyrinogen III biosynthetic process [GO:0006780]","GO:0004852; GO:0005542; GO:0005739; GO:0005829; GO:0006780; GO:0006782; GO:0006783; GO:0046677; GO:0070541; GO:0071243; GO:0071418"
"1715",1715,"Cluster_2973","Pocillopora_meandrina_HIv1___Sc0000026:4212263-4213263",168,-25.78,2,18,453,475,17,"88.24%","88.24%","Pocillopora_meandrina_HIv1___RNAseq.g12194.t1",0.951315168814306,0.0128005069263181,0.674410729954476,NA,NA,NA,NA,NA
"1717",1717,"Cluster_2973","Pocillopora_meandrina_HIv1___Sc0000027:1157690-1158690",163,-21.62,2,21,913,935,20,"70.00%","85.00%","Pocillopora_meandrina_HIv1___RNAseq.g13979.t1",-0.923537212113185,0.0250878957317679,0.706073799226855,"Q9R0Q9","Mannose-P-dolichol utilization defect 1 protein (Suppressor of Lec15 and Lec35 glycosylation mutation homolog) (SL15)","Mus musculus (Mouse)","oligosaccharide biosynthetic process [GO:0009312]","GO:0009312; GO:0016020"
"1718",1718,"Cluster_2973","Pocillopora_meandrina_HIv1___Sc0000028:2882196-2883196",157,-22.57,2,21,807,826,19,"68.42%","84.21%","Pocillopora_meandrina_HIv1___RNAseq.g1018.t1",-0.899541566002569,0.0376407767862467,0.760878962620332,"Q9BYT9","Anoctamin-3 (Transmembrane protein 16C)","Homo sapiens (Human)","calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; chloride transmembrane transport [GO:1902476]; detection of mechanical stimulus [GO:0050982]; detection of temperature stimulus [GO:0016048]; establishment of localization in cell [GO:0051649]; ion transmembrane transport [GO:0034220]; transmembrane transport [GO:0055085]","GO:0005229; GO:0005254; GO:0005886; GO:0016048; GO:0017128; GO:0034220; GO:0046983; GO:0050982; GO:0051649; GO:0055085; GO:0061590; GO:0061591; GO:1902476"
"1721",1721,"Cluster_2973","Pocillopora_meandrina_HIv1___Sc0000030:688842-689842",155,-26.69,2,21,923,946,21,"61.90%","80.95%","Pocillopora_meandrina_HIv1___RNAseq.g25456.t1",0.930091115253792,0.0219545777654567,0.693734227986648,NA,NA,NA,NA,NA
"1727",1727,"Cluster_2973","Pocillopora_meandrina_HIv1___Sc0000034:562062-563062",164,-21.05,2,21,424,445,19,"68.42%","84.21%","Pocillopora_meandrina_HIv1___RNAseq.g9286.t1",0.961144507446293,0.00914039514690395,0.667107103030161,"P22984","Amidase (EC 3.5.1.4)","Rhodococcus erythropolis (Arthrobacter picolinophilus)","","GO:0004040; GO:0043864"
"1739",1739,"Cluster_2973","Pocillopora_meandrina_HIv1___Sc0000044:1531835-1532359",167,-21.8,2,21,448,470,20,"75.00%","85.00%","Pocillopora_meandrina_HIv1___RNAseq.g5012.t1",0.951315168814306,0.0128005069263182,0.674410729954476,NA,NA,NA,NA,NA
"1741",1741,"Cluster_2973","Pocillopora_meandrina_HIv1___xfSc0000000:433275-434275",153,-21.66,2,20,859,883,21,"66.67%","80.95%","Pocillopora_meandrina_HIv1___RNAseq.g6383.t1",0.951315168814306,0.0128005069263182,0.674410729954476,NA,NA,NA,NA,NA
"1744",1744,"Cluster_2973","Pocillopora_meandrina_HIv1___xfSc0000083:21482-22482",168,-22.46,2,17,182,203,15,"86.67%","93.33%","Pocillopora_meandrina_HIv1___RNAseq.g12815.t1",-0.882676643087564,0.0473823037676455,0.785789452428799,"Q8WU66","Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR)","Homo sapiens (Human)","hair cycle process [GO:0022405]; Notch signaling pathway [GO:0007219]; regulation of Notch signaling pathway [GO:0008593]; sensory perception of sound [GO:0007605]; signal transduction [GO:0007165]; tooth mineralization [GO:0034505]","GO:0005576; GO:0007165; GO:0007219; GO:0007605; GO:0008593; GO:0009986; GO:0022405; GO:0032420; GO:0034505; GO:0060170"
"1747",1747,"Cluster_3392","Pocillopora_meandrina_HIv1___Sc0000000:19344641-19345447",172,-22.77,2,21,604,625,19,"78.95%","84.21%","Pocillopora_meandrina_HIv1___RNAseq.g22593.t1",-0.937583781631645,0.0185426445340557,0.678805299657499,"Q9DC37","Major facilitator superfamily domain-containing protein 1","Mus musculus (Mouse)","protein localization to lysosome [GO:0061462]; protein stabilization [GO:0050821]","GO:0005764; GO:0005765; GO:0022857; GO:0042803; GO:0050821; GO:0061462"
"1779",1779,"Cluster_3392","Pocillopora_meandrina_HIv1___Sc0000007:11286259-11287259",170,-20.96,2,21,357,377,19,"78.95%","89.47%","Pocillopora_meandrina_HIv1___RNAseq.g6000.t1",-0.96651066577516,0.00731981147339898,0.667107103030161,"Q8IWV8","E3 ubiquitin-protein ligase UBR2 (EC 2.3.2.27) (N-recognin-2) (RING-type E3 ubiquitin transferase UBR2) (Ubiquitin-protein ligase E3-alpha-2) (Ubiquitin-protein ligase E3-alpha-II)","Homo sapiens (Human)","cellular response to leucine [GO:0071233]; heterochromatin formation [GO:0031507]; histone H2A ubiquitination [GO:0033522]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transposition [GO:0010529]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596]","GO:0000151; GO:0000785; GO:0005634; GO:0005737; GO:0005829; GO:0007131; GO:0007140; GO:0007141; GO:0007283; GO:0008270; GO:0010529; GO:0016567; GO:0031507; GO:0032007; GO:0033522; GO:0061630; GO:0070728; GO:0071233; GO:0071596"
"1796",1796,"Cluster_3392","Pocillopora_meandrina_HIv1___Sc0000015:7559275-7560275",169,-22.48,2,20,901,921,18,"77.78%","94.44%","Pocillopora_meandrina_HIv1___RNAseq.g4703.t2",-0.951291348936714,0.0128098558578028,0.674410729954476,"Q28BT8","tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like (EC 1.3.1.89) (mRNA-dihydrouridine synthase DUS3L) (EC 1.3.1.-) (tRNA-dihydrouridine synthase 3-like)","Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)","mRNA processing [GO:0006397]; regulation of translation [GO:0006417]; tRNA dihydrouridine synthesis [GO:0002943]","GO:0002943; GO:0006397; GO:0006417; GO:0017150; GO:0046872; GO:0050660"
"1897",1897,"Cluster_360","Pocillopora_meandrina_HIv1___Sc0000018:8229836-8230836",159,-21.03,2,21,381,405,22,"68.18%","77.27%","Pocillopora_meandrina_HIv1___RNAseq.g28829.t1",-0.900932125154022,0.0368698953875627,0.759511171900781,NA,NA,NA,NA,NA
"1952",1952,"Cluster_3661","Pocillopora_meandrina_HIv1___Sc0000006:5274173-5274820",156,-22.8,2,21,9,30,19,"68.42%","73.68%","Pocillopora_meandrina_HIv1___RNAseq.g27216.t1",0.905785707797582,0.0342195578492726,0.748826538606318,"Q9R088","Thymidine kinase 2, mitochondrial (EC 2.7.1.21) (2'-deoxyuridine kinase TK2) (EC 2.7.1.74) (Deoxycytidine kinase TK2) (EC 2.7.1.-) (Mt-TK)","Mus musculus (Mouse)","deoxycytidine metabolic process [GO:0046092]; deoxyribonucleotide metabolic process [GO:0009262]; DNA biosynthetic process [GO:0071897]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial DNA replication [GO:0006264]; phosphorylation [GO:0016310]; thymidine metabolic process [GO:0046104]","GO:0004137; GO:0004797; GO:0005524; GO:0005737; GO:0005739; GO:0005743; GO:0006264; GO:0009262; GO:0016310; GO:0019136; GO:0032042; GO:0046092; GO:0046104; GO:0071897"
"1976",1976,"Cluster_3661","Pocillopora_meandrina_HIv1___Sc0000009:4557770-4557955",155,-22.11,2,21,53,77,22,"59.09%","81.82%","Pocillopora_meandrina_HIv1___RNAseq.g14406.t1",-0.947205501961073,0.0144459929648385,0.674410729954476,NA,NA,NA,NA,NA
"1999",1999,"Cluster_3661","Pocillopora_meandrina_HIv1___Sc0000015:1294379-1295379",161,-20.64,2,20,668,688,18,"77.78%","83.33%","Pocillopora_meandrina_HIv1___RNAseq.g4219.t1",-0.893589248725178,0.0409973517032514,0.764958405044081,"Q6PF21","Methionine--tRNA ligase, cytoplasmic (EC 6.1.1.10) (Methionyl-tRNA synthetase) (MetRS)","Xenopus laevis (African clawed frog)","methionyl-tRNA aminoacylation [GO:0006431]","GO:0000049; GO:0004825; GO:0005524; GO:0005730; GO:0005829; GO:0006431; GO:0017101"
"2045",2045,"Cluster_3661","Pocillopora_meandrina_HIv1___xfSc0000817:1397-1649",157,-20.51,2,20,82,108,23,"69.57%","78.26%","Pocillopora_meandrina_HIv1___RNAseq.g17855.t1",-0.939862308606942,0.0175427271704768,0.674410729954476,NA,NA,NA,NA,NA
"2136",2136,"Cluster_390","Pocillopora_meandrina_HIv1___Sc0000014:5251967-5252967",161,-22.31,2,20,699,719,18,"72.22%","88.89%","Pocillopora_meandrina_HIv1___RNAseq.g26279.t1",0.9386147969895,0.0180879604571439,0.675155050026976,"Q6UPE0","Choline dehydrogenase, mitochondrial (CDH) (CHD) (EC 1.1.99.1)","Rattus norvegicus (Rat)","glycine betaine biosynthetic process from choline [GO:0019285]","GO:0005743; GO:0008812; GO:0016491; GO:0019285; GO:0050660"
"2147",2147,"Cluster_390","Pocillopora_meandrina_HIv1___Sc0000021:3812968-3813876",169,-24.49,2,20,877,900,20,"80.00%","90.00%","Pocillopora_meandrina_HIv1___RNAseq.g10909.t1",-0.896259939547683,0.0394800324057806,0.760878962620332,NA,NA,NA,NA,NA
"2237",2237,"Cluster_4040","Pocillopora_meandrina_HIv1___Sc0000000:11513398-11514398",149,-20.79,2,18,314,335,16,"68.75%","75.00%","Pocillopora_meandrina_HIv1___RNAseq.g22033.t1",0.972985140112875,0.00530848037077797,0.667107103030161,NA,NA,NA,NA,NA
"2255",2255,"Cluster_4040","Pocillopora_meandrina_HIv1___Sc0000001:18481104-18482104",165,-27.91,2,21,389,410,20,"75.00%","90.00%","Pocillopora_meandrina_HIv1___RNAseq.g20238.t1",-0.892856711751098,0.0414167041800821,0.766125859823191,"Q9JLR1","Protein transport protein Sec61 subunit alpha isoform 2 (Sec61 alpha-2)","Mus musculus (Mouse)","post-translational protein targeting to membrane, translocation [GO:0031204]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]","GO:0005048; GO:0005784; GO:0006616; GO:0008320; GO:0031204; GO:0043022"
"2256",2256,"Cluster_4040","Pocillopora_meandrina_HIv1___Sc0000001:1893334-1893965",151,-26.22,2,21,33,56,21,"66.67%","71.43%","Pocillopora_meandrina_HIv1___RNAseq.g18711.t1",-0.89222103570171,0.0417817050411097,0.767454121234386,NA,NA,NA,NA,NA
"2267",2267,"Cluster_4040","Pocillopora_meandrina_HIv1___Sc0000002:14373966-14374966",153,-23.47,2,19,908,930,18,"72.22%","77.78%","Pocillopora_meandrina_HIv1___RNAseq.g7611.t1",0.895774961352802,0.0397542110457143,0.760878962620332,NA,NA,NA,NA,NA
"2291",2291,"Cluster_4040","Pocillopora_meandrina_HIv1___Sc0000003:17893129-17894129",155,-26.05,2,21,221,243,20,"70.00%","75.00%","Pocillopora_meandrina_HIv1___RNAseq.g16493.t1",0.923133357394691,0.0252853472181017,0.707095036888693,"Q7RTR2","NLR family CARD domain-containing protein 3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (NACHT, LRR and CARD domains-containing protein 3) (Nucleotide-binding oligomerization domain protein 3)","Homo sapiens (Human)","I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of tumor necrosis factor production [GO:0032720]; T cell activation [GO:0042110]","GO:0005524; GO:0005737; GO:0005829; GO:0007249; GO:0014067; GO:0032088; GO:0032687; GO:0032688; GO:0032715; GO:0032720; GO:0034451; GO:0035556; GO:0036312; GO:0042110; GO:0043124; GO:0043231; GO:0045824; GO:0048147; GO:0048471; GO:0050680; GO:0050728; GO:1900016; GO:1900226; GO:1901223"
"2301",2301,"Cluster_4040","Pocillopora_meandrina_HIv1___Sc0000004:11046832-11047832",159,-20.37,2,16,90,111,14,"85.71%","85.71%","Pocillopora_meandrina_HIv1___RNAseq.g24984.t1",0.967323743914835,0.00705573256531476,0.667107103030161,"Q7TT16","Inositol polyphosphate multikinase (EC 2.7.1.140) (EC 2.7.1.151) (EC 2.7.1.153) (Inositol 1,3,4,6-tetrakisphosphate 5-kinase)","Mus musculus (Mouse)","inositol phosphate biosynthetic process [GO:0032958]; inositol trisphosphate metabolic process [GO:0032957]; necroptotic process [GO:0070266]; neural tube formation [GO:0001841]; phosphorylation [GO:0016310]","GO:0000823; GO:0000824; GO:0000825; GO:0001841; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0008440; GO:0016301; GO:0016310; GO:0032957; GO:0032958; GO:0046872; GO:0046934; GO:0047326; GO:0051765; GO:0052812; GO:0070266; GO:0097243; GO:0102732"
"2314",2314,"Cluster_4040","Pocillopora_meandrina_HIv1___Sc0000005:629481-630481",144,-20.72,2,16,820,839,14,"71.43%","85.71%","Pocillopora_meandrina_HIv1___RNAseq.g22915.t2",0.964688308357655,0.00792314923256851,0.667107103030161,NA,NA,NA,NA,NA
"2319",2319,"Cluster_4040","Pocillopora_meandrina_HIv1___Sc0000005:8676462-8677462",162,-24.66,2,19,480,501,17,"70.59%","88.24%","Pocillopora_meandrina_HIv1___RNAseq.g23558.t1",0.961298934008182,0.0090861713829669,0.667107103030161,NA,NA,NA,NA,NA
"2333",2333,"Cluster_4040","Pocillopora_meandrina_HIv1___Sc0000007:3494380-3495380",147,-22.26,2,12,362,383,10,"90.00%","90.00%","Pocillopora_meandrina_HIv1___RNAseq.g5404.t1",0.925765015875986,0.0240077130581381,0.69930919566774,NA,NA,NA,NA,NA
"2337",2337,"Cluster_4040","Pocillopora_meandrina_HIv1___Sc0000007:556451-557451",151,-22.09,2,16,473,494,14,"64.29%","92.86%","Pocillopora_meandrina_HIv1___RNAseq.g5118.t1",0.976826321823201,0.00421998498719735,0.667107103030161,NA,NA,NA,NA,NA
"2341",2341,"Cluster_4040","Pocillopora_meandrina_HIv1___Sc0000007:9892680-9893680",159,-25.72,2,21,331,353,20,"65.00%","85.00%","Pocillopora_meandrina_HIv1___RNAseq.g5926.t1",0.961298934008182,0.00908617138296699,0.667107103030161,NA,NA,NA,NA,NA
"2350",2350,"Cluster_4040","Pocillopora_meandrina_HIv1___Sc0000008:9840369-9841369",157,-27.95,2,18,960,981,16,"62.50%","93.75%","Pocillopora_meandrina_HIv1___RNAseq.g2559.t1",0.953961731899305,0.0117757958811372,0.674410729954476,NA,NA,NA,NA,NA
"2351",2351,"Cluster_4040","Pocillopora_meandrina_HIv1___Sc0000008:9925907-9926907",167,-21.56,2,20,441,462,18,"72.22%","88.89%","Pocillopora_meandrina_HIv1___RNAseq.g2567.t1",-0.946710306900266,0.0146486093787309,0.674410729954476,NA,NA,NA,NA,NA
"2360",2360,"Cluster_4040","Pocillopora_meandrina_HIv1___Sc0000010:4681990-4682990",145,-24.03,2,18,354,375,16,"62.50%","75.00%","Pocillopora_meandrina_HIv1___RNAseq.g13293.t1",-0.955613031752267,0.0111507536875778,0.672484450209773,"Q5ZIJ9","E3 ubiquitin-protein ligase MIB2 (EC 2.3.2.27) (Mind bomb homolog 2) (RING-type E3 ubiquitin transferase MIB2)","Gallus gallus (Chicken)","Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]","GO:0004842; GO:0005737; GO:0007219; GO:0008270; GO:0016567"
"2397",2397,"Cluster_4040","Pocillopora_meandrina_HIv1___Sc0000017:3535705-3536705",172,-24.15,2,21,262,283,19,"68.42%","94.74%","Pocillopora_meandrina_HIv1___RNAseq.g29177.t1",0.961298934008182,0.00908617138296702,0.667107103030161,NA,NA,NA,NA,NA
"2410",2410,"Cluster_4040","Pocillopora_meandrina_HIv1___Sc0000018:4258825-4259825",153,-23.1,2,21,943,962,19,"68.42%","78.95%","Pocillopora_meandrina_HIv1___RNAseq.g28449.t1",0.94938772594496,0.0135641566469084,0.674410729954476,NA,NA,NA,NA,NA
"2412",2412,"Cluster_4040","Pocillopora_meandrina_HIv1___Sc0000018:802096-803096",153,-21.62,2,21,698,720,21,"71.43%","76.19%","Pocillopora_meandrina_HIv1___TS.g8006.t1",0.961298934008182,0.00908617138296695,0.667107103030161,NA,NA,NA,NA,NA
"2428",2428,"Cluster_4040","Pocillopora_meandrina_HIv1___Sc0000025:4239669-4240669",158,-21.58,2,20,555,577,19,"68.42%","84.21%","Pocillopora_meandrina_HIv1___RNAseq.g16906.t1",0.985770892516738,0.00203315846884277,0.667107103030161,"Q9JJT0","RNA 3'-terminal phosphate cyclase-like protein","Mus musculus (Mouse)","endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; rRNA processing [GO:0006364]","GO:0000447; GO:0000479; GO:0000480; GO:0004521; GO:0005730; GO:0006364"
"2432",2432,"Cluster_4040","Pocillopora_meandrina_HIv1___Sc0000025:4817160-4818160",154,-23.35,2,20,538,560,19,"63.16%","84.21%","Pocillopora_meandrina_HIv1___RNAseq.g16975.t1",0.898753656871272,0.0380798211447792,0.760878962620332,"Q9JJT0","RNA 3'-terminal phosphate cyclase-like protein","Mus musculus (Mouse)","endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; rRNA processing [GO:0006364]","GO:0000447; GO:0000479; GO:0000480; GO:0004521; GO:0005730; GO:0006364"
"2486",2486,"Cluster_4118","Pocillopora_meandrina_HIv1___Sc0000010:9841609-9841775",175,-21.55,2,20,70,91,18,"83.33%","88.89%","Pocillopora_meandrina_HIv1___RNAseq.g13654.t2",-0.9643983944892,0.0080205715477277,0.667107103030161,"Q60769","Tumor necrosis factor alpha-induced protein 3 (TNF alpha-induced protein 3) (EC 2.3.2.-) (EC 3.4.19.12) (Putative DNA-binding protein A20) (Zinc finger protein A20)","Mus musculus (Mouse)","apoptotic process [GO:0006915]; B-1 B cell homeostasis [GO:0001922]; cell migration [GO:0016477]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to lipopolysaccharide [GO:0071222]; cytoskeleton organization [GO:0007010]; establishment of protein localization to vacuole [GO:0072666]; inflammatory response [GO:0006954]; marginal zone B cell differentiation [GO:0002315]; negative regulation of autophagy [GO:0010507]; negative regulation of B cell activation [GO:0050869]; negative regulation of CD40 signaling pathway [GO:2000349]; negative regulation of cell death [GO:0060548]; negative regulation of chronic inflammatory response [GO:0002677]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of granuloma formation [GO:0002632]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070429]; negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070433]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; negative regulation of toll-like receptor 5 signaling pathway [GO:0034148]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of Wnt signaling pathway [GO:0030177]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K11-linked deubiquitination [GO:0035871]; protein K29-linked deubiquitination [GO:0035523]; protein K33-linked deubiquitination [GO:1990168]; protein K48-linked deubiquitination [GO:0071108]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked deubiquitination [GO:0070536]; regulation of germinal center formation [GO:0002634]; regulation of immunoglobulin production [GO:0002637]; regulation of innate immune response [GO:0045088]; response to molecule of bacterial origin [GO:0002237]; response to muramyl dipeptide [GO:0032495]; response to wounding [GO:0009611]; tolerance induction to lipopolysaccharide [GO:0072573]","GO:0001922; GO:0002020; GO:0002237; GO:0002315; GO:0002632; GO:0002634; GO:0002637; GO:0002677; GO:0003677; GO:0004842; GO:0004843; GO:0005634; GO:0005737; GO:0005764; GO:0006915; GO:0006954; GO:0007010; GO:0008022; GO:0008270; GO:0009611; GO:0010507; GO:0016477; GO:0016579; GO:0019900; GO:0030177; GO:0031397; GO:0032088; GO:0032495; GO:0032691; GO:0032703; GO:0032715; GO:0032720; GO:0034115; GO:0034140; GO:0034148; GO:0035523; GO:0035871; GO:0042802; GO:0043124; GO:0043130; GO:0043621; GO:0045088; GO:0045732; GO:0045736; GO:0045824; GO:0048662; GO:0050728; GO:0050869; GO:0060548; GO:0061578; GO:0070301; GO:0070429; GO:0070433; GO:0070530; GO:0070536; GO:0070936; GO:0071108; GO:0071222; GO:0071947; GO:0072573; GO:0072666; GO:1902042; GO:1990168; GO:2000347; GO:2000349; GO:2000352"
"2497",2497,"Cluster_4118","Pocillopora_meandrina_HIv1___Sc0000034:2820440-2820561",168,-21.28,2,20,7,26,18,"83.33%","88.89%","Pocillopora_meandrina_HIv1___RNAseq.g9431.t1",0.880236608444019,0.0488495050336766,0.789717381455039,NA,NA,NA,NA,NA
"2502",2502,"Cluster_4435","Pocillopora_meandrina_HIv1___Sc0000000:19165999-19166999",157,-22.7,2,21,945,970,23,"73.91%","78.26%","Pocillopora_meandrina_HIv1___RNAseq.g22570.t1",0.939223190890111,0.0178213805478248,0.674410729954476,NA,NA,NA,NA,NA
"2596",2596,"Cluster_4435","Pocillopora_meandrina_HIv1___Sc0000019:4670984-4671984",160,-21.1,2,21,858,879,19,"68.42%","78.95%","Pocillopora_meandrina_HIv1___TS.g21248.t1",0.946798679669328,0.0146123829398806,0.674410729954476,NA,NA,NA,NA,NA
"2643",2643,"Cluster_4437","Pocillopora_meandrina_HIv1___Sc0000000:8087038-8087703",165,-20.55,2,18,9,29,16,"81.25%","87.50%","Pocillopora_meandrina_HIv1___RNAseq.g21698.t1",-0.936440048092366,0.0190513058777132,0.682865205121081,"P38571","Lysosomal acid lipase/cholesteryl ester hydrolase (Acid cholesteryl ester hydrolase) (LAL) (EC 3.1.1.13) (Cholesteryl esterase) (Lipase A) (Sterol esterase)","Homo sapiens (Human)","cell morphogenesis [GO:0000902]; epithelial cell proliferation [GO:0050673]; homeostasis of number of cells within a tissue [GO:0048873]; inflammatory response [GO:0006954]; lipid catabolic process [GO:0016042]; low-density lipoprotein particle clearance [GO:0034383]; lung development [GO:0030324]; macrophage homeostasis [GO:0061519]; sterol metabolic process [GO:0016125]; tissue remodeling [GO:0048771]","GO:0000902; GO:0001650; GO:0004771; GO:0005654; GO:0005764; GO:0005829; GO:0006954; GO:0016042; GO:0016125; GO:0016298; GO:0030324; GO:0034383; GO:0043202; GO:0043231; GO:0048771; GO:0048873; GO:0050673; GO:0061519"
"2686",2686,"Cluster_4437","Pocillopora_meandrina_HIv1___Sc0000005:3259951-3260951",157,-20.97,2,20,836,855,18,"72.22%","83.33%","Pocillopora_meandrina_HIv1___TS.g16019.t1",-0.902369461047844,0.0360784551317628,0.756927516725757,NA,NA,NA,NA,NA
"2690",2690,"Cluster_4437","Pocillopora_meandrina_HIv1___Sc0000006:1116969-1117969",161,-22.13,2,20,128,152,22,"72.73%","81.82%","Pocillopora_meandrina_HIv1___RNAseq.g26767.t1",-0.913771393287824,0.0299993888671437,0.730775150642326,NA,NA,NA,NA,NA
"2706",2706,"Cluster_4437","Pocillopora_meandrina_HIv1___Sc0000008:2922246-2923246",164,-23.73,2,20,456,474,18,"77.78%","88.89%","Pocillopora_meandrina_HIv1___TS.g4417.t1",-0.915146070217129,0.029291083822897,0.727535937165873,NA,NA,NA,NA,NA
"2795",2795,"Cluster_4437","Pocillopora_meandrina_HIv1___Sc0000038:1724703-1725703",167,-20.2,2,20,615,635,18,"77.78%","83.33%","Pocillopora_meandrina_HIv1___RNAseq.g29874.t1",0.912502869199818,0.0306578011395566,0.734251425733176,NA,NA,NA,NA,NA
"2834",2834,"Cluster_4438","Pocillopora_meandrina_HIv1___Sc0000002:11263806-11264806",153,-22.96,2,21,337,356,19,"68.42%","78.95%","Pocillopora_meandrina_HIv1___RNAseq.g7317.t2",-0.956341015669562,0.0108787641585293,0.669251440057929,"Q5VTL8","Pre-mRNA-splicing factor 38B (Sarcoma antigen NY-SAR-27)","Homo sapiens (Human)","mRNA processing [GO:0006397]; RNA splicing [GO:0008380]","GO:0003723; GO:0006397; GO:0008380; GO:0071011"
"2862",2862,"Cluster_4438","Pocillopora_meandrina_HIv1___Sc0000005:4155678-4156678",166,-23.54,2,19,538,559,17,"76.47%","88.24%","Pocillopora_meandrina_HIv1___RNAseq.g23227.t1",0.895299567906285,0.0400235567571623,0.760878962620332,NA,NA,NA,NA,NA
"2870",2870,"Cluster_4438","Pocillopora_meandrina_HIv1___Sc0000006:12975462-12976462",162,-25.1,2,15,280,301,13,"84.62%","100.00%","Pocillopora_meandrina_HIv1___TS.g15372.t1",0.954983880231116,0.0113875812378623,0.674410729954476,"Q8TE73","Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5)","Homo sapiens (Human)","cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158]","GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0005930; GO:0007018; GO:0007368; GO:0007507; GO:0008569; GO:0021670; GO:0030286; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051649; GO:0051959; GO:0060271; GO:0097728; GO:0097729"
"2903",2903,"Cluster_4438","Pocillopora_meandrina_HIv1___Sc0000010:1647373-1647575",160,-22.67,2,21,40,61,19,"63.16%","84.21%","Pocillopora_meandrina_HIv1___RNAseq.g13008.t1",0.917011847713688,0.0283384858232937,0.723308277112744,NA,NA,NA,NA,NA
"2969",2969,"Cluster_4438","Pocillopora_meandrina_HIv1___Sc0000020:2185694-2186694",156,-25.95,2,21,256,274,19,"68.42%","84.21%","Pocillopora_meandrina_HIv1___TS.g7023.t1",0.895299567906285,0.0400235567571623,0.760878962620332,NA,NA,NA,NA,NA
"2973",2973,"Cluster_4438","Pocillopora_meandrina_HIv1___Sc0000023:2349944-2350944",160,-22.31,2,21,180,201,19,"68.42%","78.95%","Pocillopora_meandrina_HIv1___RNAseq.g17618.t1b",0.895299567906285,0.0400235567571622,0.760878962620332,"Q9JI12","Vesicular glutamate transporter 2 (VGluT2) (Differentiation-associated BNPI) (Differentiation-associated Na(+)-dependent inorganic phosphate cotransporter) (Solute carrier family 17 member 6)","Rattus norvegicus (Rat)","anion transport [GO:0006820]; brain development [GO:0007420]; hippocampus development [GO:0021766]; hyaloid vascular plexus regression [GO:1990384]; L-glutamate import [GO:0051938]; L-glutamate transmembrane transport [GO:0015813]; neural retina development [GO:0003407]; neurotransmitter loading into synaptic vesicle [GO:0098700]; neurotransmitter uptake [GO:0001504]; phosphate ion homeostasis [GO:0055062]; phosphate ion transport [GO:0006817]; regulation of synapse structure or activity [GO:0050803]; sodium-dependent phosphate transport [GO:0044341]; synaptic transmission, glutamatergic [GO:0035249]","GO:0001504; GO:0003407; GO:0005254; GO:0005313; GO:0005326; GO:0005436; GO:0005769; GO:0005886; GO:0006817; GO:0006820; GO:0007420; GO:0008021; GO:0015386; GO:0015813; GO:0016020; GO:0021766; GO:0022857; GO:0030672; GO:0034707; GO:0035249; GO:0043005; GO:0044341; GO:0050803; GO:0051938; GO:0055062; GO:0060076; GO:0098700; GO:0098793; GO:0140787; GO:0140788; GO:1990030; GO:1990384"
"3020",3020,"Cluster_4438","Pocillopora_meandrina_HIv1___Sc0000049:109185-110185",144,-22.38,2,19,943,970,23,"65.22%","69.57%","Pocillopora_meandrina_HIv1___RNAseq.g6426.t1",0.895299567906285,0.0400235567571623,0.760878962620332,NA,NA,NA,NA,NA
"3058",3058,"Cluster_4439","Pocillopora_meandrina_HIv1___Sc0000001:8128579-8129579",151,-23.68,2,18,662,682,16,"75.00%","81.25%","Pocillopora_meandrina_HIv1___RNAseq.g19288.t1",-0.953732653183663,0.011863382770165,0.674410729954476,"Q9H6P5","Threonine aspartase 1 (Taspase-1) (EC 3.4.25.-) [Cleaved into: Threonine aspartase subunit alpha; Threonine aspartase subunit beta]","Homo sapiens (Human)","positive regulation of DNA-templated transcription [GO:0045893]; protein maturation [GO:0051604]; proteolysis [GO:0006508]","GO:0004298; GO:0005737; GO:0006508; GO:0042802; GO:0045893; GO:0051604"
"3119",3119,"Cluster_4439","Pocillopora_meandrina_HIv1___Sc0000006:8530564-8531564",155,-20.67,2,21,356,380,22,"68.18%","72.73%","Pocillopora_meandrina_HIv1___RNAseq.g27544.t1",-0.910731350231389,0.0315849265630151,0.738554322750861,"Q0VBN2","Dermatan-sulfate epimerase-like protein (EC 5.1.-.-)","Mus musculus (Mouse)","chondroitin sulfate metabolic process [GO:0030204]; dermatan sulfate metabolic process [GO:0030205]","GO:0008146; GO:0016020; GO:0030204; GO:0030205; GO:0047757"
"3148",3148,"Cluster_4439","Pocillopora_meandrina_HIv1___Sc0000010:9981254-9982254",150,-20.55,2,16,296,319,16,"75.00%","81.25%","Pocillopora_meandrina_HIv1___RNAseq.g13665.t1",-0.918714847116492,0.0274778888213581,0.718250718096923,NA,NA,NA,NA,NA
"3177",3177,"Cluster_4439","Pocillopora_meandrina_HIv1___Sc0000014:7424716-7425716",146,-20.92,2,20,342,364,19,"68.42%","68.42%","Pocillopora_meandrina_HIv1___RNAseq.g26491.t1",-0.88883008471585,0.0437458539750245,0.774345884403092,"P70426","GTP-binding protein Rit1 (EC 3.6.5.2) (Ras-like protein expressed in many tissues) (Ras-like without CAAX protein 1)","Mus musculus (Mouse)","Ras protein signal transduction [GO:0007265]","GO:0003924; GO:0003925; GO:0005516; GO:0005525; GO:0005886; GO:0007265; GO:0019003"
"3232",3232,"Cluster_4439","Pocillopora_meandrina_HIv1___Sc0000023:5300984-5301948",147,-25.53,2,20,701,724,21,"71.43%","76.19%","Pocillopora_meandrina_HIv1___RNAseq.g17817.t2",0.88893396386542,0.0436852594930444,0.774279675195074,"Q9H7T0","Cation channel sperm-associated auxiliary subunit beta (CatSper-beta)","Homo sapiens (Human)","cell differentiation [GO:0030154]; spermatogenesis [GO:0007283]","GO:0005886; GO:0005929; GO:0007283; GO:0030154; GO:0036128; GO:0097228"
"3314",3314,"Cluster_4572","Pocillopora_meandrina_HIv1___Sc0000000:9201092-9202092",157,-21.19,2,20,913,936,20,"75.00%","80.00%","Pocillopora_meandrina_HIv1___TS.g26522.t1",0.913644352178685,0.0300651210105492,0.731230875671148,NA,NA,NA,NA,NA
"3325",3325,"Cluster_4572","Pocillopora_meandrina_HIv1___Sc0000002:8482793-8482997",165,-23.73,2,21,77,96,19,"78.95%","84.21%","Pocillopora_meandrina_HIv1___RNAseq.g7090.t1",0.955756133992673,0.0110971143594629,0.672291781568494,NA,NA,NA,NA,NA
"3351",3351,"Cluster_4572","Pocillopora_meandrina_HIv1___Sc0000008:3732003-3733003",157,-20.55,2,16,852,872,14,"85.71%","92.86%","Pocillopora_meandrina_HIv1___TS.g4491.t1",-0.893123431004372,0.041263859383206,0.765547441916077,"Q9ZQ81","Probable inactive purple acid phosphatase 9","Arabidopsis thaliana (Mouse-ear cress)","","GO:0003993; GO:0005576; GO:0046872"
"3377",3377,"Cluster_4572","Pocillopora_meandrina_HIv1___Sc0000014:5074291-5075291",156,-25.36,2,21,24,42,19,"68.42%","84.21%","Pocillopora_meandrina_HIv1___RNAseq.g26253.t1",0.922381777461385,0.0256541337627968,0.709493339104897,NA,NA,NA,NA,NA
"3385",3385,"Cluster_4572","Pocillopora_meandrina_HIv1___Sc0000018:6611030-6612030",157,-22.54,2,19,804,828,20,"70.00%","80.00%","Pocillopora_meandrina_HIv1___RNAseq.g28667.t1",0.907492047308069,0.0333029339906323,0.744826055124395,NA,NA,NA,NA,NA
"3387",3387,"Cluster_4572","Pocillopora_meandrina_HIv1___Sc0000019:1581035-1582035",163,-20.54,2,20,269,290,18,"77.78%","77.78%","Pocillopora_meandrina_HIv1___RNAseq.g18019.t1",0.916697076903221,0.0284984852930961,0.724119943915209,"Q05915","GTP cyclohydrolase 1 (EC 3.5.4.16) (GTP cyclohydrolase I) (GTP-CH-I)","Mus musculus (Mouse)","7,8-dihydroneopterin 3'-triphosphate biosynthetic process [GO:0035998]; cellular response to lipopolysaccharide [GO:0071222]; dihydrobiopterin metabolic process [GO:0051066]; dopamine biosynthetic process [GO:0042416]; negative regulation of blood pressure [GO:0045776]; neuromuscular process controlling posture [GO:0050884]; positive regulation of heart rate [GO:0010460]; positive regulation of nitric-oxide synthase activity [GO:0051000]; protein-containing complex assembly [GO:0065003]; pteridine-containing compound biosynthetic process [GO:0042559]; regulation of blood pressure [GO:0008217]; regulation of lung blood pressure [GO:0014916]; regulation of removal of superoxide radicals [GO:2000121]; regulation of serotonin biosynthetic process [GO:1905627]; response to pain [GO:0048265]; response to tumor necrosis factor [GO:0034612]; response to type II interferon [GO:0034341]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrofolate biosynthetic process [GO:0046654]; vasodilation [GO:0042311]","GO:0003924; GO:0003934; GO:0005509; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006729; GO:0008217; GO:0008270; GO:0010460; GO:0014916; GO:0030742; GO:0031369; GO:0031410; GO:0031965; GO:0032991; GO:0034341; GO:0034612; GO:0035998; GO:0042311; GO:0042416; GO:0042559; GO:0042802; GO:0042803; GO:0044877; GO:0045776; GO:0046654; GO:0048265; GO:0050884; GO:0051000; GO:0051019; GO:0051066; GO:0065003; GO:0071222; GO:1905627; GO:2000121"
"3404",3404,"Cluster_4572","Pocillopora_meandrina_HIv1___Sc0000031:4027193-4027822",163,-23.62,2,21,315,337,20,"75.00%","80.00%","Pocillopora_meandrina_HIv1___RNAseq.g1584.t1",0.907294115157397,0.0334088516215532,0.745127957735035,NA,NA,NA,NA,NA
"3413",3413,"Cluster_4572","Pocillopora_meandrina_HIv1___Sc0000041:432398-433398",162,-21.61,2,20,359,381,19,"73.68%","84.21%","Pocillopora_meandrina_HIv1___RNAseq.g25239.t1",0.895807556348497,0.039735764783443,0.760878962620332,"Q76KP1","N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1 (NGalNAc-T1) (EC 2.4.1.244) (Beta-1,4-N-acetylgalactosaminyltransferase IV) (Beta4GalNAc-T4) (Beta4GalNAcT4)","Homo sapiens (Human)","","GO:0008376; GO:0032580; GO:0033842"
"3436",3436,"Cluster_4754","Pocillopora_meandrina_HIv1___Sc0000005:12040234-12041234",167,-20.2,2,21,78,100,20,"80.00%","80.00%","Pocillopora_meandrina_HIv1___RNAseq.g23879.t1",-0.948555502501726,0.0138983189603672,0.674410729954476,NA,NA,NA,NA,NA
"3442",3442,"Cluster_4754","Pocillopora_meandrina_HIv1___Sc0000007:13185926-13186926",159,-20.59,2,21,416,441,23,"69.57%","73.91%","Pocillopora_meandrina_HIv1___RNAseq.g6179.t1",-0.951855066617466,0.0125892046006514,0.674410729954476,"Q09666","Neuroblast differentiation-associated protein AHNAK (Desmoyokin)","Homo sapiens (Human)","positive regulation of plasma membrane repair [GO:1905686]; regulation of RNA splicing [GO:0043484]; regulation of voltage-gated calcium channel activity [GO:1901385]","GO:0003723; GO:0005634; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0005925; GO:0015629; GO:0016020; GO:0030315; GO:0031982; GO:0042383; GO:0042802; GO:0043034; GO:0043484; GO:0044291; GO:0044548; GO:0045296; GO:0070062; GO:0097493; GO:0098797; GO:1901385; GO:1905686"
"3457",3457,"Cluster_4754","Pocillopora_meandrina_HIv1___Sc0000020:3809408-3810296",175,-21.2,2,20,786,807,18,"83.33%","88.89%","Pocillopora_meandrina_HIv1___RNAseq.g358.t2",0.960472587148064,0.0093775542355283,0.667107103030161,"Q86YR5","G-protein-signaling modulator 1 (Activator of G-protein signaling 3)","Homo sapiens (Human)","cell differentiation [GO:0030154]; establishment of mitotic spindle orientation [GO:0000132]; negative regulation of GTPase activity [GO:0034260]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; nervous system development [GO:0007399]; positive regulation of macroautophagy [GO:0016239]","GO:0000132; GO:0000139; GO:0001965; GO:0005092; GO:0005789; GO:0005829; GO:0005886; GO:0007399; GO:0016239; GO:0030154; GO:0032991; GO:0034260; GO:1905098"
"3494",3494,"Cluster_4823","Pocillopora_meandrina_HIv1___Sc0000002:6569820-6570820",162,-20.16,2,21,823,847,22,"72.73%","81.82%","Pocillopora_meandrina_HIv1___RNAseq.g6951.t1",0.94455976051765,0.0155391253278518,0.674410729954476,"Q68CP4","Heparan-alpha-glucosaminide N-acetyltransferase (EC 2.3.1.78) (Transmembrane protein 76)","Homo sapiens (Human)","heparan sulfate proteoglycan catabolic process [GO:0030200]; lysosomal transport [GO:0007041]; protein complex oligomerization [GO:0051259]","GO:0005765; GO:0005886; GO:0007041; GO:0015019; GO:0016746; GO:0030200; GO:0035579; GO:0043202; GO:0051259; GO:0070821"
"3498",3498,"Cluster_4823","Pocillopora_meandrina_HIv1___Sc0000003:5330172-5331172",161,-22.95,2,21,207,232,23,"78.26%","78.26%","Pocillopora_meandrina_HIv1___RNAseq.g15572.t1",-0.884455530237433,0.0463216161368451,0.782515407534089,"Q63665","Upstream stimulatory factor 2 (Major late transcription factor 2) (Upstream transcription factor 2)","Rattus norvegicus (Rat)","lactation [GO:0007595]; lipid homeostasis [GO:0055088]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter by glucose [GO:0000432]; regulation of transcription by RNA polymerase II [GO:0006357]","GO:0000432; GO:0000978; GO:0000981; GO:0003677; GO:0003690; GO:0003700; GO:0005634; GO:0006357; GO:0007595; GO:0042802; GO:0042803; GO:0043425; GO:0043565; GO:0044877; GO:0045893; GO:0045944; GO:0046982; GO:0055088; GO:1990837"
"3506",3506,"Cluster_4823","Pocillopora_meandrina_HIv1___Sc0000005:3896972-3897972",172,-20.2,2,21,168,189,19,"73.68%","89.47%","Pocillopora_meandrina_HIv1___RNAseq.g23200.t1",0.897645908812525,0.0386998270607946,0.760878962620332,"P70085","Steroid 17-alpha-hydroxylase/17,20 lyase (EC 1.14.14.19) (EC 1.14.14.32) (17-alpha-hydroxyprogesterone aldolase) (CYPXVII) (Cytochrome P450 17A1) (Cytochrome P450-C17) (Cytochrome P450c17)","Oryzias latipes (Japanese rice fish) (Japanese killifish)","hormone biosynthetic process [GO:0042446]; progesterone metabolic process [GO:0042448]; steroid biosynthetic process [GO:0006694]","GO:0004508; GO:0005506; GO:0006694; GO:0016020; GO:0020037; GO:0042446; GO:0042448; GO:0047442"
"3533",3533,"Cluster_4823","Pocillopora_meandrina_HIv1___Sc0000009:462758-463031",155,-22.26,2,12,217,238,10,"100.00%","100.00%","Pocillopora_meandrina_HIv1___RNAseq.g14264.t1",-0.961719612589991,0.00893899667046301,0.667107103030161,"P17987","T-complex protein 1 subunit alpha (TCP-1-alpha) (CCT-alpha)","Homo sapiens (Human)","binding of sperm to zona pellucida [GO:0007339]; chaperone-mediated protein folding [GO:0061077]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of macrophage apoptotic process [GO:2000109]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998]; translocation of peptides or proteins into host cell cytoplasm [GO:0044053]; tubulin complex assembly [GO:0007021]","GO:0000242; GO:0000792; GO:0001669; GO:0002199; GO:0003723; GO:0005524; GO:0005794; GO:0005813; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007021; GO:0007339; GO:0016887; GO:0031625; GO:0032212; GO:0044053; GO:0044183; GO:0044297; GO:0050821; GO:0051082; GO:0051973; GO:0061077; GO:0070062; GO:0090666; GO:0140662; GO:1901998; GO:1904851; GO:1904871; GO:1904874; GO:2000109"
"3536",3536,"Cluster_4823","Pocillopora_meandrina_HIv1___Sc0000009:8449601-8450601",152,-20.14,2,20,703,724,19,"68.42%","84.21%","Pocillopora_meandrina_HIv1___RNAseq.g14538.t3",0.884148822126808,0.0465039524686314,0.783039820420276,"Q9WUU9","Germinal-center associated nuclear protein (GANP) (EC 2.3.1.48) (GC-associated DNA primase)","Mus musculus (Mouse)","mRNA export from nucleus [GO:0006406]; nucleosome organization [GO:0034728]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein transport [GO:0015031]; somatic hypermutation of immunoglobulin genes [GO:0016446]","GO:0003676; GO:0003682; GO:0004402; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0006406; GO:0010484; GO:0015031; GO:0016446; GO:0016973; GO:0031965; GO:0034728; GO:0042393; GO:0044615; GO:0070390"
"3585",3585,"Cluster_4823","Pocillopora_meandrina_HIv1___Sc0000036:1579456-1580456",157,-22.93,2,21,45,67,21,"71.43%","80.95%","Pocillopora_meandrina_HIv1___RNAseq.g17228.t1",0.907054870799809,0.033537019935001,0.745629707899491,"Q9EPB1","Dipeptidyl peptidase 2 (EC 3.4.14.2) (Dipeptidyl aminopeptidase II) (Dipeptidyl peptidase 7) (Dipeptidyl peptidase II) (DPP II) (Quiescent cell proline dipeptidase)","Rattus norvegicus (Rat)","lysosomal protein catabolic process [GO:1905146]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]","GO:0004177; GO:0005576; GO:0005764; GO:0005829; GO:0006508; GO:0008236; GO:0008239; GO:0030163; GO:0031410; GO:0031982; GO:1905146"
"3602",3602,"Cluster_5253","Pocillopora_meandrina_HIv1___Sc0000000:1691461-1692461",157,-20.85,2,17,620,641,16,"87.50%","87.50%","Pocillopora_meandrina_HIv1___RNAseq.g21096.t2",-0.893969747810397,0.0407800653003234,0.763953206641785,"P00518","Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform (EC 2.7.11.19) (Phosphorylase kinase subunit gamma-1) (Serine/threonine-protein kinase PHKG1) (EC 2.7.11.1, EC 2.7.11.26)","Oryctolagus cuniculus (Rabbit)","glycogen biosynthetic process [GO:0005978]; protein phosphorylation [GO:0006468]","GO:0004689; GO:0005516; GO:0005524; GO:0005964; GO:0005978; GO:0006468; GO:0008047; GO:0050321; GO:0098723; GO:0106310"
"3648",3648,"Cluster_5612","Pocillopora_meandrina_HIv1___Sc0000000:3472773-3473039",158,-23.29,2,19,178,198,17,"76.47%","76.47%","Pocillopora_meandrina_HIv1___RNAseq.g21270.t1",0.980573011199149,0.00324095110871972,0.667107103030161,"Q27294","RNA-binding protein cabeza (P19) (Sarcoma-associated RNA-binding fly homolog)","Drosophila melanogaster (Fruit fly)","adult locomotory behavior [GO:0008344]; compound eye development [GO:0048749]; larval locomotory behavior [GO:0008345]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; regulation of DNA-templated transcription [GO:0006355]; synaptic assembly at neuromuscular junction [GO:0051124]; transcription initiation at RNA polymerase II promoter [GO:0006367]","GO:0000398; GO:0003682; GO:0003712; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005669; GO:0006355; GO:0006367; GO:0008344; GO:0008345; GO:0045887; GO:0046872; GO:0048749; GO:0051124; GO:0071013"
"3659",3659,"Cluster_5612","Pocillopora_meandrina_HIv1___Sc0000001:16963715-16964715",170,-21.09,2,19,649,669,17,"82.35%","88.24%","Pocillopora_meandrina_HIv1___RNAseq.g20078.t1",-0.88109718697942,0.0483304220790219,0.788777708312882,"Q0EEE2","Patched domain-containing protein 3 (RND-type protein RNDEu-3)","Mus musculus (Mouse)","","GO:0005783; GO:0005789; GO:0005886; GO:0016020; GO:0097225"
"3676",3676,"Cluster_5612","Pocillopora_meandrina_HIv1___Sc0000003:15031202-15032202",141,-20.29,2,17,955,979,19,"73.68%","73.68%","Pocillopora_meandrina_HIv1___RNAseq.g16311.t1",0.972468214538339,0.0054611451842724,0.667107103030161,"O73792","Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1)","Danio rerio (Zebrafish) (Brachydanio rerio)","angiogenesis [GO:0001525]; blood vessel development [GO:0001568]; endothelial cell-cell adhesion [GO:0071603]; heart development [GO:0007507]; positive regulation of angiogenesis [GO:0045766]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vasculature development [GO:0001944]","GO:0001525; GO:0001568; GO:0001944; GO:0004714; GO:0005524; GO:0005886; GO:0007169; GO:0007507; GO:0033674; GO:0043235; GO:0045766; GO:0071603"
"3719",3719,"Cluster_5612","Pocillopora_meandrina_HIv1___Sc0000017:1446678-1447678",156,-20.8,2,15,553,572,13,"92.31%","92.31%","Pocillopora_meandrina_HIv1___RNAseq.g29018.t1",0.968749174893632,0.00660054432976495,0.667107103030161,NA,NA,NA,NA,NA
"3720",3720,"Cluster_5612","Pocillopora_meandrina_HIv1___Sc0000017:3484535-3485535",145,-21.23,2,20,771,790,18,"66.67%","72.22%","Pocillopora_meandrina_HIv1___RNAseq.g29171.t1",0.957668758838898,0.0103883926944759,0.667107103030161,"Q9Y6H5","Synphilin-1 (Sph1) (Alpha-synuclein-interacting protein)","Homo sapiens (Human)","cell death [GO:0008219]; dopamine metabolic process [GO:0042417]; regulation of inclusion body assembly [GO:0090083]; regulation of neurotransmitter secretion [GO:0046928]","GO:0005654; GO:0005737; GO:0005829; GO:0008021; GO:0008219; GO:0031625; GO:0036464; GO:0042417; GO:0042734; GO:0042802; GO:0043025; GO:0046928; GO:0090083"
"3742",3742,"Cluster_5612","Pocillopora_meandrina_HIv1___Sc0000040:1373508-1374245",146,-20.01,2,15,707,727,13,"76.92%","76.92%","Pocillopora_meandrina_HIv1___RNAseq.g6314.t1",0.954536920546783,0.011556813886094,0.674410729954476,"Q5RDL2","ATP-dependent RNA helicase DDX24 (EC 3.6.4.13) (DEAD box protein 24)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","","GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0016887"
"3748",3748,"Cluster_5740","Pocillopora_meandrina_HIv1___Sc0000000:3632364-3633364",158,-20.21,2,21,706,726,19,"73.68%","78.95%","Pocillopora_meandrina_HIv1___RNAseq.g21288.t1",0.97331997811525,0.00521035621847276,0.667107103030161,NA,NA,NA,NA,NA
"3750",3750,"Cluster_5740","Pocillopora_meandrina_HIv1___Sc0000004:10901525-10902525",168,-20.81,2,18,538,560,17,"88.24%","88.24%","Pocillopora_meandrina_HIv1___RNAseq.g24972.t1",0.8969792824808,0.0390744724604115,0.760878962620332,NA,NA,NA,NA,NA
"3756",3756,"Cluster_5740","Pocillopora_meandrina_HIv1___Sc0000006:13130661-13131661",166,-21.31,2,16,259,281,15,"93.33%","93.33%","Pocillopora_meandrina_HIv1___TS.g15384.t1",0.968245538327909,0.00676023042280697,0.667107103030161,NA,NA,NA,NA,NA
"3775",3775,"Cluster_6382","Pocillopora_meandrina_HIv1___Sc0000000:2638217-2639217",179,-20.09,2,20,139,160,18,"88.89%","88.89%","Pocillopora_meandrina_HIv1___RNAseq.g21187.t1",-0.92854222067375,0.0226828435551831,0.698759485874756,"Q7KTX8","Mediator of RNA polymerase II transcription subunit 13 (Mediator complex subunit 13) (Mediator complex subunit Skuld) (Protein blind spot) (Protein poils aux pattes) (dTRAP240)","Drosophila melanogaster (Fruit fly)","cell fate commitment [GO:0045165]; chaeta development [GO:0022416]; compound eye development [GO:0048749]; imaginal disc-derived leg segmentation [GO:0036011]; larval somatic muscle development [GO:0007526]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of transcription by RNA polymerase II [GO:0006357]; sex comb development [GO:0045498]; transcription initiation at RNA polymerase II promoter [GO:0006367]; wing disc dorsal/ventral pattern formation [GO:0048190]","GO:0003712; GO:0005634; GO:0005654; GO:0006357; GO:0006367; GO:0007526; GO:0016592; GO:0022416; GO:0036011; GO:0045165; GO:0045498; GO:0048190; GO:0048749; GO:0070847; GO:0090263"
"3778",3778,"Cluster_6382","Pocillopora_meandrina_HIv1___Sc0000010:11428805-11429805",154,-20.17,2,21,210,238,26,"69.23%","69.23%","Pocillopora_meandrina_HIv1___TS.g2814.t1",0.891822203696429,0.0420112308377608,0.768266681224655,NA,NA,NA,NA,NA
"3794",3794,"Cluster_757","Pocillopora_meandrina_HIv1___Sc0000006:13090153-13090431",140,-22.51,2,9,190,211,7,"100.00%","100.00%","Pocillopora_meandrina_HIv1___TS.g15377.t1",0.998017694805407,0.00010591572863792,0.657211063688294,"Q17R09","Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 (EC 3.6.4.13) (ATP-dependent RNA helicase DHX38) (DEAH box protein 38)","Bos taurus (Bovine)","mRNA splicing, via spliceosome [GO:0000398]","GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005681; GO:0016887; GO:0071013"
"3807",3807,"Cluster_757","Pocillopora_meandrina_HIv1___Sc0000018:2075909-2076909",167,-24.42,2,21,656,678,20,"75.00%","85.00%","Pocillopora_meandrina_HIv1___RNAseq.g28274.t1",-0.945598353405002,0.0151069187482363,0.674410729954476,"Q6P5D8","Structural maintenance of chromosomes flexible hinge domain-containing protein 1 (SMC hinge domain-containing protein 1) (EC 3.6.1.-)","Mus musculus (Mouse)","chromosome organization [GO:0051276]; dosage compensation by inactivation of X chromosome [GO:0009048]; double-strand break repair [GO:0006302]; inactivation of X chromosome by heterochromatin formation [GO:0060820]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; nose development [GO:0043584]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]","GO:0000781; GO:0001740; GO:0003677; GO:0005524; GO:0006302; GO:0009048; GO:0016887; GO:0035861; GO:0042803; GO:0043584; GO:0045739; GO:0051276; GO:0060820; GO:2000042; GO:2001034"
"3810",3810,"Cluster_757","Pocillopora_meandrina_HIv1___Sc0000019:2294685-2295685",167,-27.33,2,21,646,668,20,"75.00%","85.00%","Pocillopora_meandrina_HIv1___RNAseq.g18080.t1",-0.936617126043391,0.0189722606584466,0.682197615392399,"Q7TN88","Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2)","Mus musculus (Mouse)","detection of mechanical stimulus [GO:0050982]","GO:0001965; GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982"
"3867",3867,"Cluster_925","Pocillopora_meandrina_HIv1___Sc0000018:6526140-6527140",168,-20.07,2,21,795,816,19,"78.95%","78.95%","Pocillopora_meandrina_HIv1___RNAseq.g28658.t1",-0.880690632268326,0.0485754289092945,0.789207872515656,NA,NA,NA,NA,NA
"3879",3879,"Cluster_925","Pocillopora_meandrina_HIv1___Sc0000036:1105242-1105504",157,-24.51,2,20,129,154,22,"72.73%","77.27%","Pocillopora_meandrina_HIv1___RNAseq.g17187.t1",-0.941635968703423,0.0167769397218938,0.674410729954476,NA,NA,NA,NA,NA
"3881",3881,"Cluster_925","Pocillopora_meandrina_HIv1___xfSc0000596:37086-38086",161,-25.68,2,21,397,422,24,"75.00%","75.00%","Pocillopora_meandrina_HIv1___TS.g16963.t1a",-0.9093043507048,0.0323381600075138,0.741122623532938,NA,NA,NA,NA,NA
